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ABSTRACT 
Acetate, a short-chain fatty acid that plays a key role in all domains of life, can be 
utilized as a carbon source or excreted as a product of metabolism. Acetate kinase 
(ACK), a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) enzyme 
superfamily, is responsible for the reversible phosphorylation of acetate to acetyl 
phosphate utilizing ATP as the phosphoryl donor. Acetate kinases are ubiquitous in the 
Bacteria, found in one genus of Archaea, and are also present in microbes of the 
Eukarya. A partially purified ACK which can utilize pyrophosphate (PPi) as the 
phosphoryl donor in the acetyl phosphate-forming direction was previously identified in 
Entamoeba histolytica, the causative agent of amoebic dysentery. Here I describe my 
research on the E. histolytica PPi-dependent ACK.  
My biochemical and kinetic characterization of the E. histolytica ACK revealed 
several properties that are unique to this enzyme. First, the E. histolytica enzyme is 
capable of utilizing acyl substrates longer than butyrate and can utilize acyl substrates as 
long as hexanoate in the direction of acetyl phosphate synthesis. Second, this ACK can 
only utilize PPi as a phosphoryl donor and cannot utilize ATP. The kinetic parameters for 
substrate affinity indicate that the enzyme prefers both an acetate and propionate in the 
acetyl phosphate-forming direction; however, the low kcat raises question whether this 
direction of the reaction is physiological. The enzyme operates preferentially in the 
direction of acetate/PPi synthesis as the rate of catalysis and overall catalytic efficiency 
are 1,102-fold and 240,351-fold higher, respectively. Studies of the mechanism of this 
enzyme indicates that the PPi-ACK follows a sequential mechanism, supporting a direct 
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in-line phosphoryl transfer mechanism previously reported in the well characterized 
Methanosarcina thermophila ATP-dependent ACK . 
A modified hydroxamate assay was developed for measuring ACKs in the 
direction of acetate formation. A coupled enzyme assay has been used to measure ATP 
production in the direction for the prokaryotic ACKs, but there was not a method 
available for measuring a PPi-forming ACK in this direction. The assay described here 
allowed for the determination of kinetic parameters in the acetate-forming direction for 
the E. histolytica ACK and can not only be used to measure ACK activity of both ATP-
dependent and PPi-dependent acetate kinases in the direction of acetate formation, but 
could also prove useful for other enzymes that utilize activated acyl substrates such as 
acetyl adenylate and acetyl-CoA.  
Investigation of the residues in the putative PPi-ACK active site in E. histolytica 
revealed that while residues conserved across the ACK family are present in the active 
site, the enzyme has a number of significant active site changes in comparison to its 
counterpart, the M. thermophila ATP-dependent ACK. The residues His117, His172, Val87, 
Thr201, Thr15, Arg274, and Asp272 appear to be essential for catalysis in the direction of 
acetate synthesis. Furthermore, His117 appears to be critically important for binding acetyl 
phosphate and therefore important in acetate/PPi synthesis reactions. 
RNA interference of E. histolytica ACK was unable to be carried out due to 
problems with transfection of plasmid DNA into the parasite. However, data garnered 
from cellular extracts indicates that E. histolytica has a PPi-dependent ACK but not ATP-
dependent ACK. Activities of the eukaryotic ACK partner enzymes 
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phosphotransacetylase and xylulose 5-phosphate/fructose 6- phosphate phosphoketolase 
were absent in cellular extracts. The absence of bacterial ACK partner enzymes in 
Entamoeba suggests that a novel acetyl phosphate generating enzyme is the partner for 
the PPi-ACK in this protist. This speculative partner enzyme could generate acetyl 
phosphate from an intermediate of the pentose phosphate pathway or the end product of a 
yet to be identified catabolic pathway. 
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CHAPTER I 
LITERATURE REVIEW ON ACETATE KINASE AND THE PARASITE 
ENTAMOEBA HISTOLYTICA 
I. INTRODUCTION 
 Acetate, a short-chain fatty acid that plays a key role in all domains of life, can be 
utilized as a carbon source or can be excreted as a product of metabolism. The 
interconversion of acetate to acetyl-CoA is an important step in a variety of both 
catabolic and anabolic pathways and can occur via three pathways. The first pathway 
consisting of the enzymes acetate kinase (ACK) and phosphotransacetylase (PTA), is 
reversible and nearly ubiquitous in the Bacteria. ACK catalyzes the reversible transfer of 
the γ-phosphoryl group of ATP to acetate to form acetyl phosphate [EC 2.7.2.1, Eqn. 1], 
PTA then catalyzes the reversible transfer of coenzyme A (CoA) forming acetyl-CoA 
[EC 2.3.1.8; Eqn. 2]. A unidirectional ADP-forming acetyl-CoA synthetase (ADP-ACS), 
found in amitochondriate protists and some microbes in the Bacteria and Archaea, 
catalyzes the conversion of acetyl-CoA to acetate to generate ATP [EC 6.2.1.1.3, Eqn. 3]. 
Finally, the AMP-forming acetyl-CoA synthetase (AMP-ACS) is widespread in the 
Archaea, Bacteria, and Eukarya and is the predominant enzyme for activating acetate to 
acetyl-CoA [Eqn. 4]. 
 acetate + ATP ? acetyl-Pi + ADP     [Eqn. 1] 
acetyl-Pi + CoA ? acetyl-CoA + Pi    [Eqn. 2] 
acetyl-CoA + ADP + Pi → acetate + ATP   [Eqn. 3] 
acetate + ATP + CoA → acetyl-CoA + AMP + PPi  [Eqn. 4] 
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ACK, a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) enzyme 
superfamily, has recently been identified in a number of eukaryotic microbes including 
algae and oomycetes, non-yeast fungi, and a few protists including Entamoeba 
histolytica. In this chapter, the biochemistry, enzymology, and mechanism of prokaryotic 
ACKs are introduced including a thorough discussion of the Methanosarcina thermophila 
enzyme, the best characterized prokaryotic ACK. The physiological roles of ACK in the 
Bacteria and Archaea are also explored. A brief introduction to E. histolytica, which has 
a novel PPi-dependent ACK, is provided with respect to the metabolic processes of the 
parasite. 
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II. ATP-DEPENDENT ACETATE KINASES 
 
1. Physiological Roles of Acetate Kinase in the Bacteria and Archaea. 
ACK, an important enzyme in bacterial metabolism, partners with PTA forming 
one of three pathways for the interconversion of acetyl-CoA and acetate [1]. ACK and 
PTA are nearly ubiquitous in bacteria which undergo fermentation though the use of the 
AK-PTA pathway for energy conservation in the conversion of acetyl-CoA to acetate.  In 
non-fermentative bacteria, the pathway operates to activate acetate to acetyl-CoA for use 
as a carbon and/or energy source. Some bacteria such as Escherichia coli take advantage 
of the reversibility of the ACK-PTA pathway (Figure 1.1). The ACK-PTA pathway is 
used for acetate activation at high acetate concentrations while AMP-ACS is favored 
under low acetate conditions [2, 3]. Under conditions that result in mixed acid 
fermentation, acetyl-CoA cannot enter the TCA cycle and excess acetyl-CoA is used to 
produce acetate and ATP via the ACK-PTA pathway [1]. Under aerobic conditions the 
ACK-PTA pathway is used to excrete acetate and generate ATP. 
16 
 
 
Figure 1.1. The acetate switch. Bacterial pathways for acetate fermentation and the 
generation of acetyl-CoA are accomplished though an ACK/PTA pathway. Modified 
from [1]. 
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Other enzymes that can generate acetyl phosphate include pyruvate oxidase 
(POX), xylulose 5-phosphate/fructose 6-phosphate phosphoketolase (XFP), 
sulfoacetaldehyde acetyltransferase (XSC), and glycine reductase (GR). These enzymes 
have been shown to function with ACK and are found in a group of diverse bacteria, but 
not in E. coli [4]. POX, present in diverse lactobacilli and Streptococcus pneumoniae, 
catalyzes the oxidative decarboxylation of pyruvate to acetyl phosphate, carbon dioxide, 
and hydrogen peroxide. XFP, present in heterofermentative lactobacilli such as 
Bifidobacterium and Lactobacillus species, catalyzes the formation of acetyl phosphate 
and glyceraldehyde 3-phosphate (or erythrulose 4-phosphate) from xylulose 5-phosphate 
(or fructose 6-phosphate) and inorganic phosphate. XSC, present in several genera of 
Proteobacteria, cleaves sulfoacetaldehyde to acetyl phosphate and sulfite. Acetyl 
phosphate formed by these enzymes has two possible metabolic fates, either conversion 
to acetyl-CoA by PTA for anabolic pathways or conversion to acetate by ACK for ATP 
synthesis. GR is an important enzyme involved in the metabolism of glycine in some 
strictly anaerobic gram-positive bacteria such as Clostridium and Eubacterium [5]. 
Sarcosine and betaine reductases, like GR also yield acetyl phosphate as a product. In all 
three pathways, energy is formed by the ACK-catalyzed conversion of acetyl phosphate 
to ATP. 
Only two genera of methane-producing archaea, Methanosaeta and 
Methanosarcina, have been isolated that are capable of converting acetate to methane [6]. 
Methanosaeta is an obligate acetotroph and utilizes AMP-ACS to activate acetate to 
acetyl-CoA at the expense of two high-energy phosphates in the first step of 
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methanogenesis. Methanosarcina, which can also utilize carbon dioxide, methylated 
amines and methylated sulfides as energy and growth substrates [7], employs acetate 
kinase (ACK) and phosphotransacetylase (PTA) to activate acetate to acetyl-CoA [1,2]. 
Methanosarcina is the only genus in the Archaea with ACK or PTA. In both genera, 
acetyl-CoA is then cleaved at the carbon-carbon and carbon-sulfur bond by carbon 
monoxide dehydrogenase/acetyl-CoA synthetase (CODH). The carbonyl group is 
oxidized to carbon dioxide [8, 9] and the methyl group reduced to methane [10]. 
Electrons derived from CODH are transferred via ferrodoxin and an iron-sulfur 
flavoprotein to a membrane-bound electron transport system which may serve to generate 
an ion gradient for the synthesis of ATP [10-12]. 
2. Biochemistry of the Methanosarcina thermophila Acetate Kinase 
The native ACK from Methanosarcina thermophila has been purified and 
characterized [13]. The presence of high concentrations of acetate kinase in extracts of M. 
thermophila cultured on acetate supported the hypothesis that ACK functioned 
physiologically in the initial activation of acetate for the conversion to methane and 
carbon dioxide [13]. An additional supporting argument was the detected presence of 
PTA [14, 15] which would allow the conversion of ACK-generated acetyl phosphate to 
be converted to acetyl-CoA [12]. Increased levels of PTA had also been reported when 
M. thermophila was grown on acetate [12]. Furthermore, when M. thermophila was 
cultured in the presence of methanol or acetate, the synthesis of PTA was not inhibited by 
methanol, but was found to be induced by acetate in the growth medium [15].  
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The genes encoding the M. thermophila ACK and PTA were cloned and 
sequenced [14], and found to be transcribed as a single transcriptional unit with pta 
located upstream of ack and separated by an intergenic sequence [16]. Examples of acyl 
kinase/PTA genes co-expressed from the same promoter have been previously noted in E. 
coli [3] and Clostridium acetobutylicum [17]. The M. thermophila pta-ack operon was 
shown to be regulated by growth substrate. Northern blot analyses indicated that the 
steady-state levels of the pta-ack transcript were several fold greater in acetate-grown 
cells than cells grown on methanol or methylated amines [16]. Consistent with the 
transcript studies, the activities of PTA and ACK are at least 8- to 11- fold higher in 
acetate grown cells than in cells grown on other carbon and energy sources [16]. The 
development of molecular genetics tools such as in vivo transposon mutagenesis in 
Methanosarcina acetivorans [18] allowed Rother and Metcalf [19] to demonstrate that 
the pta-ack mutants could not grow on acetate as a carbon and energy source. Thus, the 
activation of acetate to acetyl-CoA in aceticlastic methanogenesis in Methanosarcina 
occurs through ACK and PTA [15]. 
 Noting the high similarity of the M. thermophila and E. coli ACKs, and the 
conservation of residues near the active site of those ACKs purified from bacteria, 
Latimer and Ferry [14] initiated a preliminary investigation of the active site of the M. 
thermophila ACK using a number of amino acid modifying agents. Using 
diethylpyrocarbonate (DEPC) and phenylglyoxal, modifiers of histidine and arginine 
respectively, they suggested that one or more arginine residues and possibly one histidine 
residue were implicated in the active site of the M. thermophila ACK [14]. This 
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hypothesis was partially supported by previous evidence of an essential arginine residue 
in the active site of the E. coli ACK which could be inactivated by chemical modification 
[20]. Further evidence was garnered by Latimer and Ferry [14] using thermal stability 
assays by comparing the optimal activity temperatures of the commercially available 
ACK from E. coli and the recombinantly produced M. thermophila ACK in order to 
further highlight the presence of an essential arginine residues by substrate protection. 
Latimer and Ferry [14] were also able to show that binding of ATP induced a 
conformational change in the ACK, thereby making the enzyme more stable. When pre-
incubated with 10 mM ATP for 5 minutes, the enzyme retained full activity up to 70°C. 
In Tris buffer alone, the enzyme was completely inactive after incubation for 5 minutes at 
55°C [14]. Although 10 mM phenylglyoxal resulted in 95% inactivation of enzyme, pre-
incubation with ATP resulted in only 61% inhibition indicating some protection from 
inactivation. However, the presence of either acetyl phosphate or acetate did not prevent 
the inactivation by phenylglyoxal [14]. This data is consistent with at least one arginine 
residue being present in the ATP active site of the ACK [14]. 
 Singh-Wissmann et al. [21] investigated five arginine residues (R91, R175, R241, 
R285, and R340) in the M. thermophila ACK which were identified as being highly 
conserved among other ACKs. R91 and R241 alanine variants displayed extremely low 
specific activities which precluded obtaining kinetic data [21]. Leucine and lysine 
alteration to these two amino acid positions resulted in specific activity ranges similar to 
the recombinant wild-type, with exception of the R91K variant which was reported to 
have a specific activity at the lower limit of detection at 0.5 µmol min-1 mg-1 [21]. While 
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considered a conservative replacement for arginine, the R91K variant displayed a kcat of 
over 100-fold lower and a Km for acetate nearly 14-fold greater than the wild-type (Table 
1.1) which implicated R91 as important for catalysis and binding of acetate [21]. A 100-
fold decrease in the kcat for ATP and more than 400-fold decrease in catalytic efficiency 
by the R91K variant in comparison to the wild-type further implicated the importance of 
this residue in catalysis. Replacement of R285 with alanine, lysine, or leucine, resulted in 
1% catalytic efficiency of the wild-type. However, an increase of nearly 10-fold in the Km 
for acetate for R285 indicated that this residue may be important for acetate binding [21]. 
Variants of R175 and R340 displayed low activity, but their respective kinetic parameters 
were not significantly altered to implicate them in substrate binding or catalysis. Thus, 
R91 and R241 are important for catalysis in the M. thermophila ACK and may be 
important for acetate binding. With the assistance of crystal structures, Gorrell et al. [22] 
later confirmed the importance of R91 and R241 in catalysis.  
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Table 1.1. Kinetic Constants of Recombinant Wild-Type and Arginine Variants of M. 
thermophila ACK. Taken from [21]. 
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 Previous research on the E. coli ACK [23] had suggested that the mechanism for 
the ACK involved a phosphoryl-enzyme intermediate, with an unspecified glutamate 
residue phosphorylated. E384, E385, and E97 in the M. thermophila ACK were identified 
as having a role in either substrate binding or catalysis (Table 1.2) [24]. E384 variants 
had very low or no detectable activity indicating an important role in catalysis. 
Replacement of E385 with alanine or aspartate did not significantly alter the kcat, but did 
significantly increase the Km values for both acetate and ATP, indicating that E385 is 
important for substrate binding, but not catalysis (Table 1.2) [24]. Changes to E97 
resulted in decreases in the Km for acetate corresponding decreases in kcat indicating that 
this residue may influence acetate binding.  
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Table 1.2. Kinetic constants of unaltered and altered ACKs from M. thermophila. 
 
a Unaltered and altered ACKs were produced in E. coli. 
b Published values for the ACK purified from M. thermophila (1) are given. 
c Apparent value. 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
In 2001, Buss et al. [25] solved the structure of the M. thermophila ACK and 
indicated that it may be the ancestral enzyme of the ASKHA (acetate and sugar 
kinases/Hsc70/actin) superfamily. The enzyme contained two domains with a duplicated 
βββαβαβα core with insertions of subdomains between elements of the β-sheet [25]. Of 
note were the numbers of highly conserved residues known to play a role in the active 
sites of other ACKs as well as other members of the ASKHA family. In the active site, 
Buss et al. [25] noted the presence of a hydrophobic pocket, composed of R285, I332, 
I339. Furthermore, the structure also confirmed the presence of H180 and H123 and the 
importance of these residues in binding the phosphate of acetyl phosphate, along with 
R91, R241, and G212 [25]. The presence of a sulfate ion in the active site from 
crystallization conditions is believed to occupy the site of the phosphate of acetyl 
phosphate. The sulfate ion ligands binding to these side chains are conserved within the 
acetate kinase-butyrate kinase family [25]. The importance of E384, a residue conserved 
among all acetate and butyrate kinases, was shown to be moved into the active site upon 
cleft closure, participating in catalysis. Known to be essential for enzyme function [24], 
Buss et al. [25] hypothesized that this residue is likely a phosphorylation site for a direct 
in-line phosphoryl transfer mechanism. 
The role of histidines in the M. thermophila ACK was investigated around the 
same time using DEPC inactivation and structure-function studies.  When incubated with 
increasing concentrations of DEPC, the M. thermophila ACK displayed both a time and 
concentration-dependent loss of enzymatic activity [26]. These results suggested the 
presence of a number of histidine residues in the active site with at least one residue 
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located directly in the active site, as previously suggested by Latimer and Ferry [14]. 
Ingram-Smith et al. [26] identified a conserved histidine residue H180 as essential for 
catalysis and hypothesized that this residue could potentially function as a hydrogen bond 
donor or positive charge stabilizer for a pentacoordination transition state for a direct, in-
line mechanism proposed earlier [27]. 
Miles et al. [28] further confirmed the importance of E384 on catalysis in the M. 
thermophila ACK. A 30-fold increase in the magnesium concentration was required for 
half-maximum activity of the E384A variant, implicating this residue in magnesium 
binding. Furthermore, D148 and N7 variants resulted in catalytic efficiencies of less than 
1% of the native M. thermophila ACK.  Miles et al. [28] proposed that the third 
stabilization site, required for a direct, in-line phosphoryl transfer mechanism as proposed 
by Blättler and Knowles [27], may be a magnesium ion stabilized by E384 and N7, with 
R91 and R241 serving as the other two stabilization sites.  
 Using the solved structure of the M. thermophila ACK, Ingram-Smith et al. [29] 
identified a hydrophobic pocket formed by the residues V93, L122, F179, and P232 in 
the active site cleft of the enzyme which is hypothesized to serve as the acetate-binding 
site (Figure 1.2). Changes to these residues resulted in significant increases in the Km for 
acetate (Table 1.3) highlighting the contribution of these residues in acetate binding [29]. 
Alteration of V93 to alanine and glycine resulted in 14-fold and 26 fold respective 
increases in the Km for acetate. The P232A variant displayed a 21-fold increase in acetate 
affinity compared to the wild type. Specifically, the identification of the F179 is 
important with respect to other members of the ASKHA enzyme family, as this residue is 
27 
 
conserved in all acetate, propionate, and butyrate kinases [25]. Members of this family 
undergo a catalytically-required domain closure [30-32], characterized by the presence of 
a glycine residue forming a phenylalanine-glycine pair. This structural architecture, 
which has been observed in glycerol kinase [32, 33], hexokinase [34], and 
phosphoglycerate kinase [35] was also observed by these researchers [29] in acetate and 
propionate kinases. The 233-fold and 99-fold decrease in respective turnover and 
catalytic efficiency for acetyl phosphate observed for the F179A variant also highlights 
the importance of this residue in the active site [29]. F179 is located at the N terminus of 
the helix α3, a bridge between domains I and II with respect to ASKHA superfamily 
structures [25]. 
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Figure 1.2. Structure of the ACK dimer from M. thermophila. Areas in red represent 
clefts of the binding pockets. Taken from [25]. 
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Table 1.3. Kinetic parameters of wild-type and variant ACKs assayed in the direction of 
acetyl phosphate 
synthesis.
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3. The Catalytic Mechanism of Acetate Kinase 
The studies of the catalytic mechanisms of ACKs have been limited to the E. coli 
and M. thermophila enzymes. The E. coli ACK was first described by Lipmann in 1944 
and finally isolated by Rose [36] in 1954. The majority of research performed on the E. 
coli enzyme has been limited to mechanistic studies with the earliest information 
concerning the mechanism in 1972. A phosphoenzyme intermediate was generated by 
incubating the enzyme with either  γ-32P-ATP or acetyl 32P-phosphate [37]. This result 
was consistent with the enzyme functioning through a ping-pong mechanism where the 
enzyme and ATP reacted to form a phosphoenzyme, and then a phosphoryl transfer from 
the phosphoenzyme to acetate to form acetyl phosphate. The phosphoenzyme 
intermediate was shown to be capable of phosphoryl transfer to either ADP or acetate 
[37, 38]. A caveat to this proposed mechanism was that the substrate exchange rates for 
ADP/ATP and acetate/acetyl phosphate were less than the rate of catalysis. In fact, one 
report indicated a 7-fold faster ADP/ATP exchange reaction than the reported rate of 
catalysis [39]. In the same report, the acetate/the acetyl phosphate rate of exchange was 
64-fold slower than the rate of catalysis [39], and a second report indicated no detectable 
exchange of acetate/acetyl phosphate [36]. Furthermore, reported slower exchange rates 
for acetate/acetyl phosphate in the presence of ATP, culminated in these researchers 
inability to exclude that reactions were occurring in both the acetate/ATP and the acetyl 
phosphate/ADP directions; and therefore, may not be limited to one particular direction 
[40]. 
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Since the initial mechanistic studies two phosphoryl transfer mechanisms have 
been proposed for ACK [22, 41]. In a single displacement mechanism, a direct 
phosphoryl transfer occurs from the gamma phosphate of ATP to acetate. In 1980, 
Spector [41], based on the evidence of the phosphoenzyme intermediate, proposed a 
triple-displacement mechanism where the gamma phosphate of ATP is transferred over 
two separate enzyme sites before final transfer to acetate [27]. The reaction would be 
characterized by a net inversion of configuration of the phosphorus atom during transfer 
from ATP to acetate. While the presence of the phosphoenzyme intermediate had been 
previously demonstrated [37], Spector [41] noted that a direct transfer was sterically 
problematic; as experimental evidence on tetra- and penta-coordinate phosphorus 
compounds had resulted in evidence to suggest one or more SN2-type displacements; with 
mechanisms involving steric inversions during each initial and subsequent reaction(s) 
[27, 42, 43]. He therefore proposed a triple displacement mechanism for ACK involving 
two phosphoenzyme intermediates, and three inversions of the phosphorus (Figure 1.3) to 
accommodate the steric and special requirements between the substrate binding sites in 
the enzyme  [41].  
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Figure 1.3. Representation of the active center of ACK. Associated with the nucleotide-
binding region is the catalytic carboxyl that has ATP as its immediate phosphoryl donor. 
Associated with the acetate (and acetyl-P) binding region is an unknown group (X) that 
has acetyl-P as its immediate phosphoryl donor. The phosphoryl group is reversibly 
transferable between X and the carboxyl group. All phosphoryl transfers among 
substrates and the catalytic groups proceed with steric inversion on the phosphorus. It is 
conjectured that the intermediate E-X-PO3 is at a higher energy level than E-COOPO3, 
because only the latter is isolated when the enzyme is phosphorylated by ATP or acetyl-
P. Taken from [41]. 
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More recent research on the M. thermophila ACK suggests that the enzyme 
functions through a single displacement or direct, in-line phosphoryl transfer mechanism. 
A number of phosphoryl transfer enzymes, both phosphatases and kinases, have been 
mechanistically studied using aluminium fluoride, which mimics the planar phosphoryl 
group in the transition state [44-46]. Pre-incubating the M. thermophila ACK with 
magnesium chloride, ADP, aluminium chloride, and sodium fluoride inhibited the 
activity of the enzyme by forming an abortive active site complex (Figure 1.4) [47]. 
Miles et al. [47] reported that the rate of observed inhibition was slow for enzyme-ligand 
interactions, but could be attributed to the sluggish rate of aluminium fluoride complex 
formation which had been previously observed [48]. In the absence of ADP and 
magnesium chloride (Figure 1.3, inset) no detectable loss of activity was observed [48]. 
This evidence indicated that the presence of magnesium chloride, ADP, acetate, and 
aluminium fluoride are required for maximum inhibition of the M. thermophila ACK 
(Table 1.4) [47].  
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Figure 1.4. Inhibition of M. thermophila ACK by MgCl2, ADP, AlCl3, NaF, and acetate. 
ACK (0.4 µM dimer) was pre-incubated for the indicated times in a mixture containing 
MgCl2 (10 mM), ADP (10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and potassium acetate 
(25 mM) in 100 mM BisTris buffer (pH 5.5). The enzyme activity was then assayed and 
plotted relative to 100% activity (600 µmol of acetyl phosphate/min/mg of protein) 
obtained from a control mixture in which AlCl3 and NaF were omitted. Inset, the time 
course of the activity assay after pre-incubation for 30 min with: complete inhibitory 
mixture (?), minus NaF and AlCl3 (■), minus MgCl2, ADP and acetate (♦), minus all 
components except buffer (▲). Taken from [47]. 
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Table 1.4. Inhibition of the ACK from E. coli or M. thermophila. Taken from [47]. 
 
a The enzyme (0.4 µM dimer) was pre-incubated for 30 min with MgCl2 (10 mM), ADP 
(10 mM), AlCl3 (0.1 mM), NaF (0.5 mM), and acetate (25 mM) unless otherwise noted 
before the activity was assayed. 
b 100% (approximately 600 µmol of acetyl phosphate/min/mg of protein) is the activity 
of the enzyme pre-incubated for 30 min with the indicated concentrations of MgCl2, 
ADP, and acetate. 
c 100% (approximately 630 µmol of acetyl phosphate/min/mg of protein) is the activity 
of the enzyme pre-incubated for 30 min with the indicated concentrations of MgCl2, 
ADP, and acetate. 
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Gorrell et al. [22] solved structures of the M. thermophila ACK with the ADP-
aluminium fluoride-acetate transition state analog which allowed additional examination 
of the R91 and R241, residues previously implicated in acetate binding and catalysis [21]. 
A structure with the non-hydrolyzable ATP analog ATPγS supported the evidence 
presented by Miles et al. [47] that ATPγS is bound equivalently to the binding of ATP in 
the active site displacing the β-phosphate and theoretically the γ-phosphate of ATP [22]. 
Kinetic parameters in both the acetate-forming and acetyl phosphate-forming directions 
for all of the R91 and R241 variants indicated these residues were essential for catalysis 
in the acetyl phosphate-forming direction (Table 1.5). Significant decreases in kcat values 
for R91 and R241variants in the acetate-forming direction were also observed. (Table 
1.6) [22].  
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Table 1.5. Kinetic parameters of wild-type and variant ACKs in the forward (ADP/AcP 
synthesis) direction. Taken from 
[22].
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Table 1.6. Kinetic parameters of wild-type and variant ACKs in the reverse (ATP/acetate 
synthesis) direction. Taken from 
[22].
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R91 and R241 were previously postulated to interact with the phosphoryl group of 
acetyl phosphate and the carbonyl oxygen of acetate [21]; however, Gorrell et al. [22] 
noted that the negligible changes in the Km values for acetyl phosphate for the R91 and 
R241variants did not provide sufficient evidence to implicate either residue in binding the 
phosphoryl group of acetyl phosphate. Conversely, the significant changes in the Km 
values for acetate for the R91 and R241 variants supported previous evidence for these 
two residues in acetate binding [21]. The increases in the Km values for acetate for the 
R91K and R241K variants were much less than for variants replaced with alanine and 
leucine (Table 1.5), confirming a requirement for a positive charge at these positions 
which would interact with the carboxyl group of acetate [22]. 
Gorrell et al. [22] proposed a catalytic mechanism (Figure 1.5) in which 
additional residues that are important in substrate binding and catalysis were identified. A 
role for H180 in stabilizing the transition state was previously proposed based on variant 
studies [21, 26]. In the analysis of the aluminium fluoride crystal structures, Gorrell et al. 
[22] discussed the close proximity of H180 along with the R241 residue to the aluminium 
fluoride in the structure.  They concluded that this proximity is consistent with 
stabilization of the transition state and that H180 also interacted with γ-phosphate of 
ATP.  Furthermore, evidence was provided by the new structure that supported enzyme 
catalysis involving E384, and D148 which have been implicated in magnesium binding 
[28]. 
Gorrell et al. [22] described the mechanism as a SN2 nucleophilic attack by the 
carboxyl group of acetate upon the γ-phosphate of ATP through a trigonal bipyramidal 
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transition state (Figure 1.4B), with stabilization of the equatorial oxygen atoms through 
an interaction with H180 and R241. In addition, H180 is proposed to interact with the 
phosphoryl group of acetyl phosphate similar to its interaction with acetate, which may 
implicate this residue in orientating acetyl phosphate for attack by ADP [22]. 
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Figure 1.5. Postulated mechanism of ACK from M. thermophila for the forward (AcP-
producing) reaction direction. A, ATP and acetate substrate interactions with ACK; B, 
interactions for the proposed direct in-line mechanism transition state; C, interactions of 
the products ADP and AcP with ACK. The arrows indicate direction of electron 
movement. Taken from [22]. 
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III. ACETATE KINASE IN THE EUKARYA 
 
 Although previously thought to be present in bacteria and one genus of archaea, 
ACK is now known to be present in all three domains of life [49]. Very little is currently 
known about the eukaryotic ACKs except knowledge gained from bioinformatic and 
phylogenetic analyses. Through BLAST searches, ACKs have been identified in three of 
the four fungal phyla: Ascomycota, Bastidiomycota, and Chytridiomycota [49]. In 
addition, ACK sequences have been identified in oomycetes (Phytophthora spp.), 
unicellular green alga (Chlamydomonas reinhardtii), and a protozoan parasite 
(Entamoeba histolytica) (Figure 1.6) [49]. Fungi lack PTA, and ACK has been proposed 
to instead partner with xylulose 5-phosphate/fructose 6-phosphate phosphoketolase 
(XFP) allowing sugar phosphates to be utilized to generate ATP (Figure 1.7a) [49]. 
Interestingly, eukaryotic ACKs from Phytophthora and Chlamydomonas utilize 
phosphotransacetylase (PTA) as a partner (Figure 1.7b) [49]. Furthermore, it has been 
hypothesized that the presence of two ACK ORFs and two PTA ORFs in C. reinhardtii 
may suggest the two ACK-PTA pathways operating in opposing directions which may be 
influenced by varying growth conditions [49]. Because C. reinhardtii can utilize acetate 
as a carbon growth source, the ACK-PTA pathway could allow for the generation of 
acetyl-CoA and eventually triose via the glyoxylate cycle [50]. This would be a second 
pathway for acetate activation as AMP-ACS is present in C. reinhardtii. Inversely, a 
suggested PTA-ACK pathway functioning in the direction of acetate formation would 
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allow for the generation of ATP via acetate fermentation [51]. 
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Figure 1.6. Phylogeny of ACK. The deduced amino acid sequences of acetate kinases 
(AKs) and the closely related propionate kinases (PKs) and butyrate kinases (BKs) from 
the draft and completed genome sequences available at NCBI (www.ncbi.nlm.nih.gov), 
the Broad Institute (http://www.broad.mit.edu/annotation/fgi/) and the U.S. Department 
of Energy Joint Genome Institute (http://genome.jgi-psf.org/euk_cur1.html). Sequences 
were aligned with ClustalX [21] and phylogenetic analysis was performed with MEGA 
[22] using the neighbor-joining algorithm. The data were analyzed using the complete 
deletion option and the tree was constructed using a gamma distance a=2. The reliability 
of each tree was examined with 1000 bootstrap replicates with values >80% shown. For 
brevity, only a representative set of bacterial sequences were used for the ACK tree 
presented here and the clade containing the BKs is not shown. AK sequences from 
bacteria are shown in black, archaea in blue and eukaryotes in red. Taken from [49]. 
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A.  
 
 
 
 
 
B. 
 
 
 
 
 
Figure 1.7. Proposed pathways for ACK in Eukaryotic microbes. (a) In Chlamydomonas 
reinhardtii and Phytophthora species, the ACK–PTA pathway (blue) could be used in the 
assimilation of acetate in the presence of high extracellular acetate concentrations or 
could operate in the reverse direction to generate ATP from excess acetyl-CoA. The 
presence of two ACK ORFs and two PTA ORFs in C. reinhardtii raises the possibility 
that two ACK–PTA pathways operate in opposite directions under different growth 
conditions. (b) In fungi, the ACK–XFP pathway (red) could function during growth in 
the breakdown of sugars to produce acetate and ATP. The acetate produced could then be 
converted to acetyl-CoA through the action of ACS. Taken and modified from [49]. A 
PTA (grey) is absent in fungi. 
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IV. THE PARASITE ENTAMOEBA HISTOLYTICA 
Entamoeba histolytica is a protozoan parasite of the phylum Amoebozoa. The 
parasite was first noted in 1875, but not fully described until 1903 as the causative agent 
of amoebiasis. An intestinal disease of humans, which is primarily present in Mexico, 
India, sub-Saharan Africa, and developing countries throughout the world, amoebiasis is 
a waterborne illness, causing dehydration, diarrhea, and sometimes extreme dysentery.  
Due to the limited resources of modern medicine in the remote locations where E. 
histolytica dominates, the protozoan has become a considerable source of morbidity and 
mortality, estimated to infect more than 50 million people worldwide [52]. 
The life cycle of the parasite begins with ingestion of an infectious cyst. The cyst 
form is non-dividing, and consists of a quadrinucleated structure consisting of a chitinous 
cell wall. This chitin-containing cell wall protects the cyst from the acidic environment of 
the stomach [53, 54]. Once the cyst enters the small intestine, excystation occurs, 
producing the active trophozoite. The trophozoite binds to the mucosal walls of the host’s 
colon and begins colonization. Penetration of the mucosal barrier results in disease in the 
host either by direct destruction of the intestinal epithelium, or by more hostile invasion 
of the host. Motile trophozoites of E. histolytica are capable of disseminating into other 
body tissues where abscesses can form if left untreated (Figure 1.8).  
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Figure 1.8. Life cycle of E. histolytica. The mature cyst is ingested by the human host.  
Excystation of the cyst occurs in the small intestine where the active trophozoite is 
produced. The trophozoite can then replicate by binary fission to form additional 
trophozoites, or can undergo encystation to produce a number of cysts. Cysts are passed 
into the host’s feces where water-borne transmission allows for continuation of the 
parasite’s life cycle. Taken from [55]. 
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E. histolytica has a functionally tetraploid genome; however, it has been noted that the 
ploidy of individuals varies from cell to cell [56] and in an assortment of growth 
conditions [57]. The genome consists of both linear chromosomes and circular, plasmid-
like molecules containing a low G+C content of 22.4%; with nearly all genes lacking 
introns [58, 59]. Because the genome has an unknown ploidy and complex variations in 
both cell cycles and cell structure nucleation, a consistent complete assembly of the 
genome has not been accomplished.  
Pathogenesis in E. histolytica is primarily dependent on adherence of the 
organism to the intestinal mucosa [60]. This process is accomplished by the presence of 
galactose/N-acetyl galactosamine binding receptors on the surface of the parasite and has 
been implicated in both virulence and cellular differentiation [61]. The protein has also 
been shown to play an important role in a number of other processes, including vesicle 
trafficking [62] and participation in dynamic cytoskeleton reorganization [63]. 
The production of a cytotoxic amoebapore protein has been shown to be essential 
in host invasion and nutrient sequestering in the host’s intestinal environment. Strains of 
E. histolytica lacking amoebapore-A are avirulent, implicating this protein as a critical 
factor in pathogenesis [64, 65]. The protein is responsible for the liberation of host cell 
components by the creation of these ion channels resulting in a loss of membrane 
integrality and failure, and ultimately leading to a significant loss of intestinal fluid; a 
hallmark of amoebic dysentery [66]. 
The parasite also produces a number of cystine proteases which are thought to 
degrade proteins and enzymes secreted by the host immune system [67], selectively 
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damage enteric cells [68], and participate in processing of intracellular host proteins [69] 
liberated by amoebapore.  
Treatment for E. histolytica infection typically involves the administration of two 
drugs. Metronidazole (Flagyl), a nitromidazole which interacts with protozoal ferredoxin 
of PFOR to produce toxic byproducts is used to treat invasive trophozoites. In addition, 
paromomycin (Humatin) an aminoglycoside, is used as a luminal amoebicide [70]. 
Problems arising from observed in vitro amoebic resistance to metronidazole and in vivo 
cytotoxic and nephrotoxic effects from paromomycin indicate a need for the 
identification of novel drug targets in this parasite [52]. 
ATP synthesis in E. histolytica is primarily limited to substrate-level 
phosphorylation.  The parasite lacks a mitochondrion, but does have a complete pentose 
phosphate pathway capable of metabolising various carbohydrate substrates (e.g. 
galactose, fructose, and other pentoses) [71]. Pathways for ATP synthesis via amino acid 
degradation have also been identified in the genome sequence, but glycolysis remains a 
staple pathway for ATP synthesis in the parasite [59, 72]. An extended glycolytic 
pathway is present in which pyruvate is converted to acetyl-CoA by PFOR (Figure 1.9). 
Acetyl-CoA is then converted to acetate by an ADP-forming ACS to generate ATP [73]. 
Amino acid catabolism by Entamoeba can lead to the generation of pyruvate in 
the absence of glucose. Pyruvate or other ketoacids can be formed by the metabolism of 
alanine, aspartic acid, asparagine, cystine, glutamine, glutamic acid, methionine, serine, 
threonine, and tryptophan [74, 75].  PFOR has been shown to have broad substrate 
specificity with the ability to oxidatively decarboxylate 2-ketobutanoate, oxaloacetate, 
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and 2-ketoglutarate. 2-ketobutanoate, a product of threonine and methionine catabolism, 
is converted to propionyl-CoA, which can be utilized by ADP-ACS as a substrate for 
ATP generation. Entamoeba has also been shown to grow at normal rates under restricted 
glucose and in the presence of the small chain fatty acids acetate, propionate, and 
butyrate [76].  
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Figure 1.9. Proposed metabolic pathway(s) for acetate synthesis and utilization in E. 
histolytica.  An extended glycolytic pathway is present in E. histolytica in which pyruvate 
is converted to acetyl-CoA by the PFOR. Acetyl-CoA can then be converted to acetate by 
and ADP-ACS. HK, hexokinase; 3-PGK, 3-phosphoglycerate kinase; PPDK, 
phosphoenolpyruvate dikinase; HYD, hydrogenase; PFOR, pyruvate ferrodoxin 
oxidoreductase; ADP-ACS, ADP-forming acetyl-CoA synthetase. 
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V. REMAINING QUESTIONS CONCERNING ACETATE KINASE 
 
 In 1975, Reeves and Guthrie first described a PPi-dependent ACK activity in E. 
histolytica [77]. At the time of the publication, modern molecular biology and 
biochemistry techniques for the cloning and recombinant production of enzymes were not 
possible. Due to the incomplete purification as well as limited quantity and concentration 
of the native enzyme, a complete profile of the biochemistry, kinetics, and mechanism of 
the E. histolytica ACK was not accomplished.  
 Within this dissertation, I have shown that the annotated ACK gene in the E. 
histolytica genome encodes for a PPi-dependent not ATP-dependent ACK. I have 
completed both biochemical and kinetic characterization of the recombinant E. histolytica 
PPi-dependent ACK. This work has resulted in identifying commonalities and differences 
between the ATP-dependent ACK found in M. thermophila and this unique PPi-
dependent ACK from E. histolytica. Modification of the ACK assay first developed by 
Lipmann [78], has made possible the kinetic characterization of the enzyme in the 
acetate-forming direction of the ACK reaction, the physiological reaction of the enzyme. 
Furthermore, the kinetic characterization of a number of enzyme variants has resulted in a 
better understanding of the essential amino acid residues that comprise the active site of 
this ACK. 
Characterization of this novel enzyme is significant in gaining better 
understanding of eukaryotic amitochondrial metabolism. In addition, the new assay 
described in this dissertation may serve as a basis for generating new methods for 
examining some of the other metabolic enzymes found in E. histolytica. 
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 CHAPTER II 
DIRECT DETECTION OF THE ACETATE-FORMING ACTIVITY OF THE 
ENZYME ACETATE KINASE 
Matthew L. Fowler, Cheryl J. Ingram-Smith, and Kerry S. Smith 
ABSTRACT 
A method for the determination of acetate kinase activity is described. This assay 
utilizes a direct reaction for determining enzyme activity and kinetics of acetate kinase in 
the acetate-forming direction with different phosphoryl acceptors. Furthermore, this 
method can be utilized for assaying other acetyl phosphate or acetyl-CoA utilizing 
enzymes. 
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I. INTRODUCTION 
Acetate kinase, a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) 
enzyme superfamily [1-5], is responsible for the reversible phosphorylation of acetate to 
acetyl phosphate utilizing ATP as a substrate. Acetate kinases are ubiquitous in the 
Bacteria, found in one genus of Archaea, and are also present in microbes of the Eukarya 
[6]. The most well characterized acetate kinase is that from the methane-producing 
archaeon Methanosarcina thermophila [7-14]. An acetate kinase which can only utilize 
PPi but not ATP in the acetyl phosphate-forming direction has been isolated from 
Entamoeba histolytica, the causative agent of amoebic dysentery, and has thus far only 
been found in this genus [15, 16]. 
In the direction of acetyl phosphate formation, acetate kinase activity is typically 
measured using the hydroxamate assay, first described by Lipmann [17-20], a coupled 
assay in which conversion of ATP to ADP is coupled to oxidation of NADH to NAD+ by 
the enzymes pyruvate kinase and lactate dehydrogenase [21, 22], or an assay measuring 
release of inorganic phosphate after reaction of the acetyl phosphate product with 
hydroxylamine [23]. Activity in the opposite, acetate-forming direction is measured by 
coupling ATP formation from ADP to the reduction of NADP+ to NADPH by the 
enzymes hexokinase and glucose 6-phosphate dehydrogenase [24].  
Here we describe a method for the detection of acetate kinase activity in the 
direction of acetate formation that does not require coupling enzymes, but is instead 
based on direct determination of acetyl phosphate consumption. After the enzymatic 
reaction, remaining acetyl phosphate is converted to a ferric hydroxamate complex that 
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can be measured spectrophotometrically, as for the hydroxamate assay. Thus, unlike the 
standard coupled assay for this direction that is dependent on the production of ATP from 
ADP, this direct assay can be used for acetate kinases that produce ATP or PPi.  
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II. MATERIALS AND METHODS 
 
The overall scheme of this protocol is outlined in Figure 2.1. 
1) Solution Preparation for Standard Curves and Assays 
1.1) Prepare 100 mL of a 2 mol/L solution of hydroxylamine-HCl. Weigh out 13.9 g of 
hydroxylamine hydrochloride (MW 69.49 g/mol) and dissolve in approximately 50 mL 
distilled-deionized water (ddH2O).  Adjust the pH to 7.0 using potassium hydroxide 
pellets or a concentrated solution. Bring the final volume to 100 mL. The solution can be 
stored at room temperature for up to 30 days or at 4°C for up to 90 days. 
 
1.2) Prepare 100 mL of a ferric chloride/ hydrochloric acid solution. Weigh out 13.5 g 
ferric chloride (MW 270.32 g/mol) and dissolve in approximately 50 mL ddH2O. Add 
41.3 mL concentrated hydrochloric acid (12.1 mol/L) and bring to a final volume of 100 
mL. The final concentration of ferric chloride will be 0.5 mol/L and the final 
concentration of hydrochloric acid will be 5 mol/L. The solution is stored at room 
temperature. 
 
1.3) Prepare 100 mL of a 1.84 mol/L solution of trichoroacetic acid. Weigh out 30.0 g of 
trichloroacetic acid (MW 163.39 g/mol), dissolve in ddH2O and bring the final volume to 
100 mL. The solution is stored at room temperature. 
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Protocol Scheme 
1. Generate an acetyl phosphate standard curve 
2. Dilute enzyme to desired concentration 
3. Prepare the reaction mixture and aliquot 300 µl to microcentrifuge tubes 
4. Preincubate reactions at 37°C for 1 minute 
5. Start reactions by adding enzyme at specific time intervals 
6. Add hydroxylamine at the same intervals to stop the reactions and incubate 
at 60°C for 5 minutes 
7. Add ferric chloride/trichloroacetic acid solution for color development 
8. Centrifuge tubes at 18,000 x g for 1 minute 
9. Measure absorbance at 540 nm 
10. Determine amount of acetyl phosphate consumed by comparison to the 
standard curve 
Figure 2.1. Protocol Scheme. 
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1.4) Prepare 5 mL of a 0.1 mol/L acetyl phosphate solution. Weigh out 0.092 g acetyl 
phosphate (MW 184.06 g/mol), dissolve in ddH2O and bring the final volume to 5 mL. 
Aliquot the solution to microcentrifuge tubes (0.25 mL per tube) and freeze at -20°C until 
use. Thawed solution should be placed on ice and can be used for approximately 1 hour. 
Acetyl phosphate solution that has been thawed should not be refrozen and re-used. 
 
1.5) Prepare 5 mL of a 0.1 mol/L solution of ADP. Weigh out 0.24 g of ADP (MW 472.5 
g/mol), dissolve in ddH2O, and bring the final volume to 5 mL. Aliquot the solution in 
microcentrifuge tubes (0.5 mL per tube) and freeze at -20° C until use. Keep thawed 
solution on ice until use. 
 
1.6) Prepare 50 mL of a 1 mol/L solution of Tris. Weigh out 6.06 g Tris (MW 121.14 
g/mol), and dissolve in 40 mL ddH2O. Adjust the pH of the solution to 7.0 using 
hydrochloric acid and bring final volume to 50 mL. Store solution at room temperature. 
 
1.7) Prepare 10 mL of a 1 mol/L magnesium chloride solution. Weigh out 2.03 g 
magnesium chloride (MW 203.31 g/mol), dissolve in ddH2O, and bring final volume to 
10 mL. Store the solution at room temperature. 
 
1.8) Prepare 25 mL development solution by mixing equal volumes of the ferric 
chloride/hydrochloric acid solution and the trichloroacetic acid solution. Development 
solution should be prepared fresh each day and stored at room temperature. 
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2) Preparation of an Acetyl Phosphate Standard Curve 
2.1) An acetyl phosphate standard curve is generated using known amounts of acetyl 
phosphate. A standard curve of six to eight points is suitable. The standards should range 
from 0.03 µmoles to 0.9 µmoles per 300 µL, which correlates to final concentrations of 
0.1 to 3 mmol/L. Dilute the acetyl phosphate stock solution to the appropriate 
concentrations in 100 mM Tris solution in a final volume of 300 µL. A control sample 
without acetyl phosphate should also be prepared.  
 
2.2) Incubate each standard and the control at 37°C in a heat block for 1 minute. 
 
2.3) Add 50 µL of the hydroxylamine hydrochloride solution to each standard and the 
control and mix by shaking three times. Place the standard into a 60°C heat block and 
incubate for five minutes. 
 
2.4) Add 100 µL of development solution to the standards and the control, mix by 
shaking three times, and allow color to develop for at least one minute at room 
temperature. 
 
2.5) Centrifuge all standards and the control in a microcentrifuge at 18,000 x g for 1 
minute. 
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2.6) Measure the samples spectrophotometrically at 540 nm using 1mL plastic cuvettes, 
using the control as the blank for spectrophotometry. 
 
2.7) Generate a standard curve using appropriate data analysis and graphing software 
(e.g. Kaleidagraph, Synergy Software). R2 values of 0.99 or greater are desirable. The 
data is plotted as absorbance at 540 nm versus µmoles of acetyl phosphate present. 
  
3) Assay for Acetate Kinase Activity 
3.1) Using the solutions described, prepare a reaction mix containing a final 
concentration of 0.1 mol/L Tris buffer, 10 mmol/L magnesium chloride, 5 mmol/L ADP, 
and 2 mmol/L acetyl phosphate. A 10 mL reaction mixture will require 8.2 mL ddH2O, 
1.0 mL Tris solution, 0.1 mL magnesium chloride solution, 0.5 mL ADP solution, and 
0.2 mL acetyl phosphate solution.   . Distribute the reaction mix in 300 µl aliquots to 
microcentrifuge tubes. For determination of kinetic parameters and optimization of 
substrate concentrations, one substrate can be varied and the other held at a constant 
concentration in the reactions.  
 
3.2) Pre-incubate the reactions for 1 minute at 37°C in a heat block. 
 
3.3) Add a desired amount of enzyme to the reaction and immediately return the tube to 
the 37°C heat block.  Also include a control reaction to which no enzyme is added. If 
several reactions are performed, add enzyme to the tubes at specific time intervals. Be 
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sure to keep track of time. (NOTE: The amount of enzyme to be used will need to be 
optimized to ensure that all of the acetyl phosphate or ADP substrate will not be depleted 
- see Discussion section) 
 
3.4) After 5 minutes, add 50 µL of the hydroxylamine hydrochloride solution to each 
reaction and the control, mix, and place the tubes in a 60°C heat block. If several 
reactions are being performed, this should be done at the same time interval as the 
enzyme was added. 
 
3.5) Incubate the reactions and the control for 5 minutes at 60°C. 
 
3.6) Add 100 µL of the development solution to each reaction and the control, mix, and 
place in a tube rack on the lab bench.  Allow color to develop for at least 1 minute. 
 
3.7) Centrifuge all tubes in a microcentrifuge at 18,000 x g for 1 minute. 
 
3.8) Measure samples spectrophotometrically at 540 nm using 1mL plastic cuvettes and 
determine the amount of acetyl phosphate present by comparison to the acetyl phosphate 
standard curve. 
 
3.9) The amount of acetyl phosphate substrate depleted can be determined by subtracting 
the amount of acetyl phosphate remaining after the enzymatic reaction from the amount 
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of acetyl phosphate present in the control lacking enzyme. Perform data analysis using 
appropriate data and graphing software (e.g. Kaleidagraph, Synergy Software). R2 values 
of greater than 0.97 are desirable. 
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III. RESULTS 
 
The purpose of this assay is to measure acetate kinase activity in the direction of 
acetate formation. This is done by measuring consumption of the acetyl phosphate 
substrate, as there is no easy, direct measurement for acetate production. Acetyl 
phosphate remaining after a given time during the enzymatic reaction is converted to 
acetyl hydroxamate and subsequently to ferric hydroxamate complex, which has a 
reddish color (Figure 2.2) that can be measured at 540 nm. The standard curve plotting 
absorbance versus µmoles acetyl phosphate present in the standards is used to determine 
the amount of acetyl phosphate remaining in each reaction. The standard curve should be 
linear through the zero point. A representative standard curve shown in Figure 2.3 has a 
slope of 1.2332 absorbance units per µmole acetyl phosphate present and an R2 value of 
0.99, indicating the data fits the linear equation well. The equation for the linear fit to the 
standard curve data is used for calculating the quantity of acetyl phosphate remaining in 
the reaction. The µmoles of acetyl phosphate consumed is determined as the difference 
between the µmoles of acetyl phosphate present in the control reaction lacking enzyme 
and the µmoles of acetyl phosphate remaining after the enzymatic reaction.   
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0 µmol 0.075 µmol 0.15 µmol 0.225 µmol 0.3 µmol 0.6 µmol 
 
Figure 2.2. Acetyl phosphate standards. Increasing concentrations of acetyl phosphate 
were reacted with hydroxylamine and color was developed with the ferric 
chloride/trichloroacetic acid solution as described. The control lacking acetyl phosphate 
is bright yellow, and reactions containing increasing amounts of acetyl phosphate are 
successively darker in color. This color change is measured at 540 nm. 
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For the experiment shown in Figure 2.4, the concentration of ADP was held 
constant at 5 mM and the concentration of acetyl phosphate in the reaction was varied to 
determine the Km for acetyl phosphate. As expected, this experiment demonstrates that 
the enzyme follows standard Michaelis-Menten-like kinetics for each substrate and 
produced a hyperbolic saturation curve when plotting activity versus acetyl phosphate 
concentration. The apparent Km value for acetyl phosphate was 0.27 ± 0.01 mM, which 
compares favorably to the published Km value of 0.47 ± 0.01 mM using the coupled assay 
[13]. 
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Figure 2.3. Sample acetyl phosphate standard curve. Varying concentrations of acetyl 
phosphate were reacted with hydroxylamine and ferric chloride/trichloroacetic acid and 
color development was measured at 540 nm. The absorbance at 540 nm versus mol 
acetyl phosphate was plotted and a linear fit to the data was applied. 
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Purified, recombinant M. thermophila acetate kinase was assayed using the 
described protocol. For the experiment shown in Figure 2.4, the concentration of ADP 
was held constant at 5 mmol/L and the concentration of acetyl phosphate in the reaction 
was varied to determine the Km for acetyl phosphate. As expected, this experiment 
demonstrates that the enzyme follows standard Michaelis-Menten-like kinetics for each 
substrate and produced a hyperbolic saturation curve when plotting activity versus acetyl 
phosphate concentration. The apparent Km value for acetyl phosphate was 0.27 ± 0.01 
mmol/L, which compares favorably to the published Km value of 0.47 ± 0.01 mmol/L 
using the coupled assay [13]. 
The direct assay can also be used to measure activity of acetate kinases that utilize 
substrates other than ATP, which is not possible using the standard coupled assay.  
Purified recombinant E. histolytica acetate kinase [16], which produces PPi rather than 
ATP in the acetate-forming direction, was subjected to this assay using sodium phosphate 
in place of ADP. The concentration of sodium phosphate in the reaction was held 
constant at 0.2 mol/L and the acetyl phosphate concentration was varied. As for the M. 
thermophila acetate kinase, the E. histolytica acetate kinase followed Michaelis-Menten-
like kinetics for acetyl phosphate and a hyperbolic saturation curve was observed (Figure 
2.5). The apparent Km value for acetyl phosphate was 0.50 ± 0.006 mmol/L. Reeves and 
Guthrie [15] determined a Km value of 0.06 mmol/L for acetyl phosphate for the native 
enzyme; however, their enzyme was only partially purified and their assay involved four 
coupling enzymes which were also only partially purified. Thus, it is difficult to directly 
compare these values. 
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Figure 2.4. Utilization of acetyl phosphate by the ATP-producing M. thermophila ACK. 
Enzymatic activity was determined in the direction of acetate formation in the presence 
of 5 mM ADP with varying concentrations of acetyl phosphate. Assays were performed 
in triplicate with error bars shown. 
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Figure 2.5. Utilization of acetyl phosphate by the PPi-producing E. histolytica ACK. 
Enzymatic activity in the direction of acetate formation was determined in the presence 
of 200 mM sodium phosphate with varying concentrations of acetyl phosphate. Assays 
were performed in triplicate with error bars shown. 
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IV. DISCUSSION 
The detection of acetyl phosphate in this assay is dependent upon a sufficient 
concentration of hydroxylamine hydrochloride and the concentration and acidity of the 
ferric chloride solution. Alteration of the assay volume will require reconsideration of 
both of these components. The enzymatic reactions described here were performed at 
37°C with the hydroxylamine termination performed at 60°C for 5 minutes. This higher 
temperature is critical to allow for rapid conversion of the remaining acetyl phosphate to 
acetyl hydroxamate. The timing of the color development step and measurement of 
absorbance is less critical, and can be performed in as little as 5 minutes and up to 15 
minutes following the addition of the hydroxylamine solution. The samples should be 
centrifuged before reading the absorbance, as the acidity of the sample may lead to 
precipitation of the enzyme and can produce a falsely high reading due to turbidity rather 
than actual color change. Breakdown of the developed reactions will begin to occur after 
10-15 minutes. 
The primary complications of this assay for examining enzyme kinetics are 
determination of the amount of enzyme to use and the length of time to run the first step 
of the reaction. These must be determined empirically for each enzyme such that the level 
of activity is not so high that all of the acetyl phosphate substrate is consumed. Careful 
attention should be given to the percent acetyl phosphate consumption for each reaction 
point in a kinetic curve.  Generally, lower concentrations of the varied component on a 
kinetic curve should result in acetyl phosphate consumption up to 90 percent or slightly 
above, while consumption of acetyl phosphate at saturating substrate concentrations 
85 
 
should approach 10 percent or slightly less.  Once the enzyme concentration is optimized, 
the substrate range for determination of kinetic constants can then be determined. 
Previous methods for measuring acetate kinase activity in the acetate-forming direction 
involved the use of coupled assays.  These methods are problematic with respect to 
kinetic calculations due to dependence on the activity of the coupling enzyme(s), whose 
assay conditions (pH, ionic strength, temperature, etc.) may be incompatible with the 
optimal assay conditions for the enzyme of interest. In addition, use of a direct assay for 
studies with inhibitors may avoid issues that could arise from inhibition of the coupling 
enzymes. Overall, this assay should be useful not only for acetate kinase, but for any 
enzyme that utilizes acetyl phosphate or other activated short chain acyl substrates such 
as acetyl- or propionyl-CoA, propionyl phosphate, and acetyl-AMP, all of which are 
reactive with hydroxylamine. In these cases, the standard curve would be generated with 
the appropriate acyl substrate instead of with acetyl phosphate. 
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CHAPTER III 
BIOCHEMICAL AND STRUCTURAL CHARACTERIZATION OF A  
NOVEL PPI-DEPENDENT ACETATE KINASE FROM THE PARASITE 
ENTAMOEBA HISTOLYTICA 
 
Matthew L. Fowler, Tarjani M. Thaker, Mikio Tanabe,  
Cheryl Ingram-Smith, Tina M. Iverson, and Kerry S. Smith 
 
ABSTRACT 
Acetate kinase (ACK) catalyzes the reversible magnesium dependent synthesis of 
acetyl phosphate by transfer of the γ-phosphate of ATP to acetate. Here we report the 
biochemical, kinetic, and structural characterization of the E. histolytica ACK, the only 
known member of the ASKHA structural superfamily that utilizes PPi as the sole 
phosphoryl donor.  The enzyme is capable of utilizing acyl substrates as long as 
hexanoate in the direction of acetyl phosphate synthesis. The kinetic parameters for 
substrate affinity indicate that the enzyme prefers both acetate and propionate in the 
acetyl phosphate-forming direction; however, the low kcat raises question whether this 
direction of the reaction is physiological. Studies of the mechanism of this enzyme 
indicates that the PPi-ACK follows a sequential mechanism, supporting a direct in-line 
phosphoryl transfer mechanism previously reported in the most well characterized 
Methanosarcina thermophila ATP-dependent ACK. We determined the crystal structure 
of the E. histolytica ACK to 2.4Å resolution. The structure contains two monomers 
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related by pseudo two-fold rotational symmetry to form a dimer. This overall shape is 
similar to that observed in other members of the ASKHA superfamily. Comparison of the 
structure of the E. histolytica ACK to that of M. thermophila ACK determined in the 
presence of both ADP•AlF4- and acetate suggests the presence of one active site in each 
monomer, with two active sites in each dimer. Docking models indicate that acetate binds 
to a location structurally analogous to the acetate binding site in the M. thermophila 
ACK, and the pyrophosphate binding to a location structurally analogous to the β-
phosphate and AlF4 of the ADP-AlF4 binding site in MtACK. Docking simulations could 
not identify a reasonably binding site for either ATP or ADP within the E. histolytica 
ACK structure. ATP binding is sterically unfeasible in the E. histolytica further 
supporting the role of this enzyme as a PPi-dependent ACK.  
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I. INTRODUCTION 
Acetate kinase (ACK), a key enzyme in energy generation in prokaryotic 
metabolism, catalyzes the reversible transfer of the γ-phosphoryl group of ATP to acetate 
to form acetyl phosphate and ADP (equation 1). 
CH3COO- + ATP  ↔  CH3COPO42- + ADP  [1] 
ACK is a member of the ASKHA phosphotransferase superfamily, which includes 
acetate kinase, hexokinase and other sugar kinases, as well as the Hsp70 heat shock 
cognate and actin [1-4]. In 2001, Buss et al. [5] published the first structure for an ACK, 
that from the archaeon Methanosarcina thermophila, and suggested that ACK is the 
urkinase for the ASKHA superfamily.  
 Several crystal structures have now been solved for the well characterized M. 
thermophila ACK [5, 6] and the roles of a number of active site residues in substrate 
binding and catalysis have been examined experimentally [7-12]. Kinetic and structural 
studies support a direct in-line transfer of the phosphoryl group of ATP to acetate. The 
positions of the ATP ligand and the proposed acetate binding pocket in the M. 
thermophila ACK structure are consistent with direct in-line transfer of the phosphoryl 
group [5, 6]. Furthermore, a MgADP-AlF3-acetate transition state analog [12] resulted in 
an abortive complex and was found to be in a linear array in the active site [6]. Based on 
analysis of site-altered enzyme variants [7, 11, 13] and structural studies, Gorrell et al. [6] 
have postulated a mechanism detailing the roles of active site residues in catalysis. The 
active site residues implicated in this mechanism are well conserved among the ACKs, 
consistent with their key roles in catalysis. 
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In 1975, Reeves and Guthrie [14] identified a PPi-dependent ACK activity in 
Entamoeba histolytica, an amitochondriate protist that is the causative agent of amoebic 
dysentery and is currently listed as the third leading cause of morbidity and mortality due 
to parasitic disease in humans after malaria and schistosomiasis [15]. Here we report the 
biochemical, kinetic, and structural characterization of the E. histolytica ACK, the only 
known member of the ASKHA structural superfamily that utilizes PPi as the sole 
phosphoryl donor.  
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II. RESULTS 
E. histolytica has a PPi-dependent ACK. In 1962, Bragg and Reeves [16] 
reported an ATP-dependent ACK in the non-pathogenic E. histolytica strain Laredo (now 
Entamoeba moshkovskii). However, this strain was grown in the presence of bacteria, 
raising the possibility that this activity was of bacterial origin. Thirteen years later, 
Reeves and Guthrie [14] identified a pyrophosphate (PPi)-dependent ACK in axenically-
grown E. histolytica. The deduced amino acid sequence of the ACK ORF (EHI_170010; 
XM 650898.1) identified in the E. histolytica genome shares 34% identity and 53% 
similarity to the well-characterized M. thermophila ACK (MtACK), which utilizes ATP 
but not PPi as the phosphoryl donor and displays high activity in both directions of the 
reaction [17]. To determine whether the encoded enzyme is indeed a PPi-dependent ACK 
and to allow kinetic and biochemical characterization, recombinant E. histolytica ACK 
(EhACK) was produced in E. coli and purified by nickel affinity chromatography to 
electrophoretic homogeneity.  
The purified recombinant enzyme utilized PPi as a phosphoryl donor in the acetyl 
phosphate-forming direction of the reaction (Figure 3.1a) and displayed normal 
hyperbolic saturation curves for both acetate and PPi. Unlike all other characterized 
ACKs, EhACK shows only PPi-dependent activity in the direction of acetyl phosphate 
formation. ATP does not serve as a phosphoryl donor (Figure 3.1a) nor do other NTPs 
(CTP, GTP, TTP, UTP, and ITP; data not shown) or ADP. In the acetate-forming 
direction of the reaction, the enzyme displayed a normal hyperbolic saturation curve with 
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inorganic phosphate as the phosphoryl acceptor, and no activity was observed with ADP, 
AMP, or PPi in the acetate-forming direction (Figure 3.1b). 
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Figure 3.1. Utilization of different phosphoryl donors and acceptors by EhACK.  (A) 
Enzymatic activity in the acetyl phosphate-forming direction of the reaction in the 
presence of 1 M acetate with varying concentrations of each phosphoryl donor was 
measured using the hydroxamate assay. (?) PPi, (?) ADP, and (?) ATP. (B) Enzymatic 
activity in the direction of acetate formation in the presence of 2 mM acetyl phosphate 
with varying concentrations of each phosphoryl acceptor was determined using the 
modified reverse hydroxamate assay. (?) Pi, (?) PPi, (?) ADP, and (?) AMP. 
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EhACK prefers the acetate/PPi-forming direction of the reaction 
In the acetate/ATP-forming direction of the reaction, the apparent Km value for 
acetyl phosphate was determined to be 0.5 ± 0.1 mM and the kcat was 1939 ± 14 sec-1 
(Table 3.1). In the acetyl phosphate/Pi-forming direction of the reaction, the Km value for 
acetate was 106.8 ± 1 mM and the kcat value was 1.76 ± 0.01 sec-1 (Table 3.1). The 
significantly higher Km value for acetyl phosphate versus acetate combined with the over 
1000-fold higher kcat observed with acetyl phosphate suggest that the physiological 
direction of the reaction is acetate/PPi formation.  
In the acetyl phosphate/Pi-forming direction of the reaction, EhACK was found to 
have a broad acyl substrate range, utilizing substrates as long as octanoate (C8). Although 
the apparent Km value decreased with increasing acyl chain length, the turnover rate kcat 
also decreased (Table 3.1). The catalytic efficiency kcat/Km with acetate was similar to that 
observed with propionate (Table 3.1), and both values were significantly higher than 
observed with any other acyl substrate. The apparent Km values for PPi remained 
relatively unchanged with different acyl substrates with the exception of hexanoate 
(Table 3.1). Activities with heptanoate and octanoate were too low for determination of 
kinetic parameters, and the enzyme was not able to use the branched-chain acyl substrates 
2-methylpropionate, 2-methylbutyrate, 3-methylbutyrate, 2-methylvalerate, 3-
methylvalerate, or 4-methylvalerate. Other acyl phosphates are not commercially 
available and therefore acetyl phosphate was the only substrate tested in the acetate/PPi-
forming direction. The enzyme utilizes the cofactors Mg2+ (Km=2.1 ± 0.2 mM) and Co2+ 
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(Km=5.5 ± 0.4 mM), but no activity was observed with Ca2+, Cu2+, Ni2+ or Zn2+. Use of 
Mn2+ resulted in less than 10% activity as compared to Mg2+.  
To determine whether EhACK follows a sequential mechanism as shown by 
Miles et al. [12] for MtACK or a ping pong mechanism consistent with a phosphoenzyme 
intermediate as proposed by Anthony and Spector [18-20], we measured activity in the 
acetate/PPi-forming direction in an array of reactions in which the acetyl phosphate and Pi 
concentrations were varied. The double reciprocal plots of the activities versus substrate 
concentrations resulted in intersecting lines (Figures 2A and B), consistent with a ternary 
(sequential) mechanism and supporting a direct transfer of the phosphoryl group between 
Pi and acetyl phosphate, similar to the in-line ternary mechanism for MtACK [12]. 
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Table 3.1. Kinetic parameters for EhACK. 
Substrate Km (mM) kcat (s-1) 
kcat/Km 
(mM-1 sec-1) 
Phosphoryl 
substrate 
Km (mM) 
Acetyl phosphate 0.5 ± 0.1 1939 ± 14 3846 ± 69 Pi 48.9 ± 0.8 
      
acetate 106.8 ± 1.0 1.76 ± 0.01 0.016 ± 0.001 PPi 3.6 ± 0.1 
propionate 79.8 ± 1.9 1.16 ± 0.01 0.015 ± 0.001 PPi 4.8 ± 0.3 
butyrate 75.6 ± 1.5 0.33 ± 0.01 0.0043 ± 0.0001 PPi 3.2 ± 0.1 
valerate 56.7 ± 0.7 0.19 ± 0.01 0.0034 ± 0.0001 PPi 6.3 ± 0.1 
hexanoate 20.5 ± 0.5 0.051 ± 0.001 0.0025 ± 0.0001 PPi 16.3 ± 0.4 
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Figure 3.2. Double reciprocal plot of acetate-forming activity of EhACK. (a) The 
reciprocal of the sodium  phosphate concentration (40 mM, 50 mM, 60 mM, and 70 mM) 
versus the reciprocal specific activity at acetyl phosphate concentrations of (?) 0.5 mM, 
(?) 0.7 mM, (?) 1.0 mM, and (?) 1.5 mM. (b) The reciprocal of the acetyl phosphate 
concentration of 0.5 mM, 0.7 mM, 1.0 mM, and 1.5 mM versus the reciprocal specific 
activity at sodium phosphate concentrations of (?) 40 mM, (?) 50 mM, (?) 60 mM, 
and (?) 70 mM. 
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Structure of E. histolytica ACK   
We determined the crystal structure of EhACK to 2.4Å resolution. The structure 
contains two monomers related by pseudo two-fold rotational symmetry to form a dimer. 
This overall shape is similar to that observed in other members of the ASKHA 
superfamily, which have previously been described as resembling the appearance of a 
bird. In order to form this bird-like structure, the N- and C-termini of each monomer fold 
into separate domains, with the C-terminal domain forming the “body” of the bird and 
mediating dimerization, and the N-terminal domain forming the “wing” of the bird 
(Figures 3.3A and 3.3B). Like other ASKHA family proteins, the C-terminal domain of 
each EhACK monomer adopts the ribonuclease H-like motif, which is comprised of a 
mixed β-sheet flanked by α-helical insertions (α/β/α fold) (Supplemental Figure 3.1) [1]. 
This ribonuclease H-like motif has greater sequence and structural similarity to the M. 
thermophila ACK (for example, 36% identity, and a RMS deviation of 1.4 Å for 240 Cα 
atoms) than does the wing domain (for example 31% identity, and a RMS deviation of 
1.4 Å for 101 Cα atoms). The lower sequence and structural identity is especially in the 
first 70 amino acids of the wing domain, which have only 21% sequence identity between 
EhACK and MtACK. 
Active site architecture 
 Co-crystallization of EhACK with acetate or pyrophosphate did not result in the 
appearance of new electron density. However, a comparison of the structure of EhACK to 
that of MtACK (PDB entry 1TUY) [6] determined in the presence of both ADP•AlF4- and 
acetate suggests the presence of one active site in each monomer, with two active sites in 
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each dimer. These active sites are positioned on opposite faces of the dimer at interfaces 
between the wing and body domains, and are separated by 35 Å (Figures 3.3 and 3.4). 
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Figure 3.3. Overall architecture of EhACK. The E. histolytica ACK dimer is shown as a 
ribbon diagram with the N-terminus of the protein (residues 1-142) colored in green, and 
the C-terminus (residues 143-392) colored in silver-blue. The active site and location of 
the predicted binding sites for products are highlighted with a dashed oval indicating the 
likely binding sites for pyrophosphate and the dashed triangle indicating the likely 
binding location for acetate. (A) The protein is shown in the orientation that most 
resembles a bird, with the N-termini of each monomer forming the wings, and the C-
termini forming the body and mediating dimerization. The Figure 3.is aligned along the 
pseudo two-fold of the body, which is represented with a silver-blue line. The wing 
domains are related by a shifted pseudo two-fold axis, which is shown as a green line. (B) 
A view of the E. histolytica ACK dimer rotated by 90°. 
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Figure 3.4. Comparison of active site structure between MtACK and EhACK. (A) 
Surface of MtACK showing cleft with docked ligands. (B) Surface of EhACK in same 
orientation. (C) Stereo overlay of MtACK and EhACK showing side chains and docked 
products. 
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Docking of acetate and pyrophosphate, the putative products of the physiological 
reaction catalyzed by EhACK, resulted in reasonable poses for each (Figure 3.4). In this 
docking model, the acetate binds to a location structurally analogous to the acetate 
binding site in MtACK, and the pyrophosphate binding to a location structurally 
analogous to the β-phosphate and AlF4 of the ADP-AlF4 binding site in MtACK (Figure 
3.4A and 4B). With the exception of the Pro ? Thr substitution at position 223, residues 
immediately surrounding both the acetate and the phosphate binding pockets are 
completely conserved between EhACK and MtACK (Figure 3.4 C). In stark contrast, 
conservative substitutions (Gly? Gln at position 323 and Ile ? Met at position 324) 
occlude the binding cleft for the adenosine ring of ATP in the EhACK enzyme (Figure 
3.4A and B), rendering the binding of ATP or ADP sterically unfeasible. Not 
surprisingly, docking simulations could not identify a reasonably scored pose for either 
ATP or ADP within the EhACK structure (data not shown). 
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IV. DISCUSSION 
Whereas ACKs in bacteria and archaea have been extensively studied, 
significantly less is known about the biochemistry of eukaryotic ACKs. Here we report 
detailed biochemical and kinetic characterization of the E. histolytica ACK, the only 
known member of the ASHKA superfamily that utilizes PPi as sole phosphoryl donor. 
Most of what is known about substrate binding and catalysis comes from studies on the 
ACK from M. thermophila. Intriguing similarities and differences between the putative 
active site of EhACK and the demonstrated active site of MtACK suggest how active site 
architecture tunes specificity for Pi/PPi versus ADP/ATP. 
An immediately notable difference is that MtACK contains a binding pocket for 
the adenosine ring of the substrate ATP that is occluded by side chains in EhACK (Figure 
3.4B) despite these two enzymes containing reasonable sequence identity in the active 
site. Two prominent alterations account for the occlusion of the site: Gly to Gln and Ile to 
Met at positions 323-324 of EhACK (positions 331-332 in MtACK) (Figure 3.4A). As a 
result, ATP binding is sterically unfeasible in the E. histolytica enzyme (Figure 3.4A).  
 In addition, EhACK contains several unusual substitutions within the acetate-
binding region of the active site, including the substitution of a Thr at position 223 in 
EhACK for a conserved Pro at the equivalent position (residue 232) in MtACK and a 
change in loop sequence and conformation between residues 110-125 of EhACK 
(residues 116-131 of MtACK). These differences alter the potential ligands to the 
acetate/acetyl phosphate substrate at two locations, and both decrease the hydrophobicity 
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of the binding pocket and add putative hydrogen bonds for acetyl phosphate (Figure 
3.4C).  
The PPi-dependent ACK activity observed in cell homogenates supports previous 
evidence suggesting that the enzyme is expressed in trophozoites. Microarray 
experiments on E. histolytica have shown that ACK is expressed in genetically distinct 
laboratory strains (HM-1:IMSS, Rahman, and 200:NIH) and in clinical isolates of both 
cysts and trophozoites (strain MS75-3544 and 2592100) in a variety of different media 
[21]. When taken together, these results indicate that ACK is expressed in both the 
infective and non-infective stages. 
The kinetic data presented here and elsewhere [14] suggests that ACK functions 
primarily in the direction of acetate/PPi formation in Entamoeba. First, EhACK activity is 
more than three orders of magnitude higher in the direction of acetate/PPi formation 
versus acetyl phosphate/Pi formation; and secondly, the enzyme has a much stronger 
affinity for acetyl phosphate than for acetate. Acetate/PPi formation catalyzed by ACK is 
consistent with the physiology of this parasite. Unlike some eukaryotes, E. histolytica 
lacks compartmentalized, ATP-generating mitochondria and hydrogenosomes and is 
therefore limited to anaerobic metabolism [22]. Glycolysis deviates from that of most 
other microbes in that PPi is used as an alternative to ATP as the phosphoryl donor in the 
steps involving phosphofructokinase and pyruvate phosphate dikinase during substrate-
level phosphorylation [14, 23, 24]. The reaction catalyzed by ACK would thus provide a 
source of PPi for these glycolytic enzymes. Furthermore, E. histolytica has been shown to 
ferment acetate during growth [14]. Although acetate is produced in the reaction 
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catalyzed by ADP-forming acetyl-CoA synthetase, which utilizes ADP for the generation 
of ATP from acetyl-CoA [25], ACK may also be responsible for acetate fermentation by 
E. histolytica.  
Although a physiological role for ACK in acetate and PPi production can be 
envisioned, the source of acetyl phosphate as a substrate is unknown. Genes encoding 
PTA or XFP, ACK’s known eukaryal partner enzymes, or other known acetyl phosphate 
producing enzymes in bacteria are absent in the latest E. histolytica genome assembly. 
Three possibilities to explain this are: (i) genes encoding PTA, XFP, or other known 
acetyl phosphate-producing enzymes are in unfinished regions of the genome; (ii) a novel 
or evolutionarily distinct class of PTA or XFP exists in Entamoeba; and (iii) a previously 
uncharacterized or undiscovered acetyl phosphate generating enzyme is present in 
Entamoeba species. Lack of XFP or PTA activity in Entamoeba cell extracts argues 
against the first two possibilities, although these activities could be labile. In bacteria, 
ACK has been shown to play a role in signaling, generating acetyl phosphate for two 
component systems or for phosphorylation of CheY and components of the PTS system 
[26-29]. However, the kinetic studies presented here do not support such a role.  
In conclusion, the Entamoeba ACK is unique among acetate kinases and the 
ASKHA enzyme superfamily in its ability to not just utilize PPi/Pi as the phosphoryl 
donor/acceptor, but to solely use PPi/Pi to the exclusion of ATP/ADP and other 
nucleotide triphosphates/diphosphates. Further examination of the crystal structure of 
EhACK and analysis of enzyme variants in both EhACK and MtACK will provide 
additional information as to the determinants of this distinctive phosphoryl donor 
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specificity. Identification of possible partners for E. histolytica ACK will provide insights 
into the function of this unique enzyme and parasite biochemistry. 
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Supplemental Figure 3.1S. Loop and wing motifs of the acetate kinase. 
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IV. MATERIALS AND METHODS 
 
Cultivation of E. histolytica and cell extract preparation 
Trophozoites of E. histolytica strain HM1:IMSS were cultured under axenic 
conditions in TYI-S-33 medium [30]. To prepare E. histolytica cell extracts, 4 x 106 
trophozoites were resuspended in 25 mM Tris, 150 mM NaCl (pH 7.4) and vortexed with 
acid-washed glass beads for one minute followed by one minute on ice, for three cycles. 
The extract was centrifuged at 5000 x g for 15 minutes and the supernatant isolated. 
Cloning the E. histolytica ACK gene 
The gene encoding the E. histolytica ACK was PCR-amplified from E. histolytica 
(strain HM1:IMSS) genomic DNA (kindly provided by Lesly Temesvari, Clemson 
University) using the primers 5’-GGAACAGGATTCATGTCTAACGTACTAATA-3’ 
and 5’-GGAACAAAGCTTTTAAAACTGAAATAATTCTTTTTC-3’and cloned into the 
E. coli expression plasmid pQE-30 (QIAGEN, Valencia, CA) in-frame with the N-
terminal His6 tag sequence using BamHI and HindIII restriction sites incorporated into 
the PCR primers. Plasmid DNA was isolated using the Zyppy Plasmid Miniprep Kit 
(Zymo Research Corp., Orange, CA).  Constructs were confirmed by sequencing 
(Clemson University Genomics Institute, Clemson, SC).   
Production and purification of recombinant E. histolytica ACK 
The Entamoeba ACK expression plasmid was transformed into Escherichia coli 
strain YBS121 ΔackApta (kindly provided by George Bennett, Rice University) along 
with the lacI-containing plasmid pREP-4 (QIAGEN) for recombinant protein production. 
Transformants were grown in LB broth containing 50 µg/ml ampicillin, 34 µg/ml 
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chloramphenicol, and 25 µg/ml kanamycin at 37°C/200 RPM to OD600≈0.9. Recombinant 
protein production was induced by the addition of isopropyl-β-D-thioglactopyranoside to 
1 mM final concentration. Cultures were incubated overnight at ambient temperature/200 
RPM and harvested by centrifugation. 
Cells were resuspended in breaking buffer (25 mM Tris, 150 mM NaCl, 20 mM 
imidazole, 10% glycerol, pH 7.4) and lysed by two passages through a French pressure 
cell at 138 MPa. Cellular debris was removed by ultracentrifugation at 100,000 x g for 1 
hour and the supernatant was applied to a 5 mL HisTrap® nickel affinity column (GE 
Healthcare, Piscataway, NJ). Protein was eluted from the column using a linear gradient 
from 0 mM to 500 mM imidazole in 25 mM Tris, 150 mM NaCl, 10% glycerol (pH 7.4). 
Fractions containing active enzyme were pooled and dialyzed against buffer containing 
25 mM Tris, 150 mM NaCl, and 10% glycerol (pH 7.4). The enzyme was determined to 
be electrophoretically pure by SDS-PAGE and Coomassie blue staining. 
Protein concentration in cellular extracts and recombinant enzyme preparations 
was quantified by the Bradford method [31] using the Bio-Rad Protein Assay with bovine 
serum albumin as standard.  
Determination of kinetic parameters for EhACK 
The hydroxamate assay [17, 32, 33] was used to determine kinetic parameters in 
the acetyl phosphate/Pi-forming direction as previously described using a reaction 
mixture containing 100 mM MES, 5 mM MgCl2, and 600 mM hydroxylamine 
hydrochloride (pH 7.5) with the concentrations of acyl substrate and sodium 
pyrophosphate were varied. Reactions were performed at 45°C, the optimal temperature 
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for this enzyme. Acetyl phosphate formation was determined by comparison to an acetyl 
phosphate standard curve. All assays were performed in triplicate. Kinetic calculations 
and progress curves were generated using Kaleidagraph (Synergy Software, Reading, 
PA).   
Kinetic parameters in the acetate/PPi-forming direction of the reaction were 
determined using a modified reverse hydroxamate assay [34]. The reactions contained 
100 mM Tris (pH 7.0), 10 mM MgCl2, and varying concentrations of sodium phosphate 
and acetyl phosphate. Reactions were performed at 37°C in triplicate. A standard curve of 
acetyl phosphate concentrations was used to determine the amount of acetyl phosphate 
depleted in the reaction.   
To examine the enzymatic mechanism, the enzyme was assayed in the direction 
of acetate/PPi formation with varied concentrations of acetyl phosphate (0.5, 0.7, 1.0, and 
1.5 mM) and sodium phosphate (40, 50, 60, and 70 mM) as a 4 x 4 matrix. All assays 
were performed in triplicate. 
Protein crystallization 
 Crystals of EhACK were grown at 20ºC using the hanging drop vapor diffusion 
method by mixing 1.0 μL of 10 mg/ml protein solution with an equal volume of reservoir 
solution [50 mM N-(2-acetamido) iminodiacetic acid (ADA) pH 6.6, 0.6 M Na-K 
Tartrate, and 10 mM FeCl3] and equilibrating against 1 ml reservoir solution. Crystals 
formed in 3 to 5 days and grew to a maximal size of approximately 0.10 × 0.10 × 0.05 
mm. Prior to data collection, the EhACK crystals were quickly dragged through a 
solution containing 50 mM ADA pH 6.6, 0.8 M Na-K Tartrate, 10 mM FeCl3, and 
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30%(w/v) (±)-2-Methyl-2,4-pentanediol (MPD), and were then flash-cooled by plunging 
in liquid nitrogen. 
X-Ray Data Collection and Processing  
X-ray diffraction data were collected on a MAR 225 CCD detector at the Life 
Sciences Collaborative Access Team (LS-CAT) beamline 21-ID-G at the Advanced 
Photon Source (Argonne, IL) using a wavelength of 0.979 Å and a temperature of 100 K. 
Data were processed and scaled using the HKL suite [35], with the best data set merging 
to 2.4 Å resolution (Table 3.2).  EhACK crystals belonged to the space group I222 with 
unit cell dimensions a = 98.8 Å, b = 126.8 Å, c = 145.5 Å, α = β= γ = 90 º.   
Structure determination, model building, and refinement 
 The EhACK structure was determined by molecular replacement using Phaser 
2.1 [36] and the coordinates of the M. thermophila acetate kinase dimer [PDB entry 1G99 
(ref), 34% sequence similarity] [5] as the search model. Iterative rounds of manual model 
building in COOT [37] and refinement in Refmac [38] and CNS [39] were performed to 
improve the quality of the model. The final model contains a dimer of EhACK in each 
asymmetric unit, which includes residues 2-32 and 39-392 of the A chain, and 2-392 of 
the B chain. The refinement achieved reasonable R-factors and geometry (Table 3.2).  
Chemicals 
Chemicals were obtained from Sigma-Aldrich, ThermoFisher Scientific, or VWR 
Scientific Products. 
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Table 3.2. Crystallographic data collection and refinement statistics 
Data Collection  
Beamline LS-CAT 21-ID-G 
Wavelength (Å) 0.979 
Space Group I222 
Resolution range (Å) 2.4 (2.46 – 2.4)a
Total reflections 273,804 
Unique reflections 35,682 
Completeness  (%) 99.3 (93.7) 
Redundancy 7.7 (5.8) 
I/σ  15.6 (3.0) 
Rsymb (%) 13.8 (44.0) 
Refinement Statistics  
Rcryst (Rfree)c (%) 20.9 (24.9) 
No. of protein atoms 5,996 
No. of solvent atoms 175 
No. of ligand atoms 0 
Average B factor 38.9 
rmsd for bond lengths (Å) 0.018 
rmsd for bond angles (°) 2.04 
Ramachandran Plot  
Most favored (%) 86.5 
Additionally allowed (%) 13.5 
Generously allowed (%) 0 
Disallowed (%) 0 
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aValues in parentheses are values for the highest resolution shell, representing the 
resolution range from 2.46 Å to 2.4 Å. 
, where I is the intensity and <I> is the weighted mean of I for 
N reflections and common indices h,k,l. 
 . 
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CHAPTER IV 
SITE-DIRECTED MUTATIONAL ANALYSIS OF ACTIVE SITE RESIDUES IN 
THE ACETATE KINASE FROM ENTAMOEBA HISTOLYTICA 
 
Matthew L. Fowler, Cheryl J. Ingram-Smith, and Kerry S. Smith 
 
ABSTRACT 
Acetate kinase (ACK) catalyzes the reversible magnesium-dependent synthesis of 
acetyl phosphate by transfer of the γ-phosphate of ATP to acetate. A novel PPi-dependent 
ACK found in E. histolytica catalyzes a similar reaction through use PPi as the 
phosphoryl donor. Using a PPi density generated model of the E. histolytica ACK, a 
structure-function approach was utilized to identify residues important for acetate-
binding and catalysis. Investigation of the residues in the putative PPi-ACK active site 
revealed that while some of the active site residues in the M. thermophila ATP-dependent 
ACK are conserved in the E. histolytica enzyme, a number of significant changes to the 
active site were found. The residues His117, His172, Val87, Thr201, Thr15, Arg274, and Asp272 
appear to be essential for catalysis in the direction of acetate synthesis. Furthermore, 
His117 appears to be critically important for binding acetyl phosphate and therefore 
important in acetate/PPi synthesis reactions. The data supports the hypothesis that the E. 
histolytica ACK operates physiologically in the direction of acetate/PPi synthesis.  
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I. INTRODUCTION 
 
Acetate kinase (ACK), an important metabolic enzyme present in all three 
domains of life [1], is a member of the acetate and sugar kinase-Hsp70-actin (ASKHA) 
enzyme superfamily [2]. This enzyme catalyzes the magnesium-dependent transfer of the 
γ-phosphate of ATP to acetate to generate acetyl phosphate. In bacteria and in the 
methane-producing archaeon Methanosarcina thermophila, the enzyme partners with 
phosphotransacetylase (PTA) in order to generate acetyl-CoA [3]. In fungi, the enzyme 
partners with xylulose 5- phosphate/fructose 6- phosphate phosphoketolase (XFP) in a 
modified pentose phosphoketolase pathway to catbolize ketose phosphates for the 
synthesis of ATP [1]. The enzyme has also been discovered in other eukaryotes such as 
Phytophthora spp., Chlamydomonas reinhardtii, and Entamoeba histolytica. In 
Phytophthora and C. reinhardtii, ACK partners with PTA to allow for the 
interconversion of acetyl phosphate and acetyl-CoA [1, 4]. 
In 1975, Reeves and Guthrie [5] partially purified a novel pyrophosphate (PPi)-
dependent ACK in Entamoeba histolytica. This enzyme was capable of utilizing acetyl 
phosphate and Pi (Eq. 1) for the synthesis of acetate. 
CH3COPO42- + Pi ? CH3COO- + PPi   (Eq. 1) 
At the time of the publication, only extracts of E. histolytica could be utilized to study the 
enzyme as recombinant techniques for generating large quantities of enzyme were not yet 
available. As such, a complete characterization of the PPi-dependent ACK could not be 
completed, and only limited information concerning the biochemistry and kinetics of the 
enzyme were obtained. 
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 More recently a biochemical and kinetic characterization of the recombinantly 
produced E. histolytica ACK has been completed [6]. Unique among ACKs, E. 
histolytica ACK can utilize PPi as a phosphoryl donor but is unable to utilize ATP [6].  
The enzyme is also capable of utilizing acyl substrates as long as hexanoate, but prefers 
acetate and propionate [6]. As previously hypothesized by Reeves and Guthrie [5] the 
enzyme preferentially operates in the direction of acetate synthesis [6]. The recent 
structure has also provided additional information on the structural makeup of the active 
site of the enzyme [6]. 
Here we report structure-function analyses of the E. histolytica ACK to identify 
amino residues that play key roles in substrate binding and or catalysis. A number of 
important residues in the active site of the well-characterized M. thermophila ACK are 
not conserved in the E. histolytica ACK. Furthermore, additional residues that play an 
important role in acetate binding and catalysis have been discovered. Residues that may 
be responsible for phosphoryl donor specificity are noted. 
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II. METHODS 
 
Protein sequence analyses 
Databases were searched at the National Center for Biotechnology Information 
using the BLAST network server [7]. ClustalX was used for multiple protein sequence 
alignments [8].  
Crystal structure modifications and modeling of variant structures 
Structures of the variants were generated using Discovery Studio Modeler® 
(Accelrys) from coordinates [6]. Modified structures were modeled using Discovery 
Studio ViewerPro® (Accelrys).  
Site-directed mutagenesis of the E. histolytica ACK 
Site-directed mutagenesis of the genes encoding the E. histolytica and ACK was 
performed using the QuickChange® Site-Directed Mutagenesis Kit (Stratagene) 
according to the manufacturer’s instructions. All mutagenic primers were 33-35 
nucleotides in length with the altered base(s) located at the middle of the sequence. The 
altered sequences were confirmed by Sanger-style sequencing at the Clemson University 
Genomics Institute (CUGI). 
Production and purification of recombinant E. histolytica ACK variants. 
Wild-type Entamoeba ACK and its variants were heterologously produced in 
Escherichia coli strain YBS121 ΔackApta (kindly provided by George Bennett, Rice 
University) along with the lacI-containing plasmid pREP-4 (Qiagen) as described 
previously [6]. Transformants were grown in LB broth containing 50 µg/ml ampicillin, 
34 µg/ml chloramphenicol, and 25 µg/ml kanamycin at 37°C/200 RPM to OD600≈0.9. 
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Recombinant protein production was induced by the addition of isopropyl-β-D-
thioglactopyranoside to 1 mM final concentration. Cultures were incubated overnight at 
ambient temperature/200 RPM and harvested by centrifugation. 
Cells were resuspended in breaking buffer (25 mM Tris, 150 mM NaCl, 20 mM 
imidazole, 10% glycerol, pH 7.4) and lysed by two passages through a French pressure 
cell at 138 MPa. Cellular debris was removed by ultracentrifugation at 100,000 x g for 1 
hour and the supernatant was applied to a 5 mL HisTrap® nickel affinity column (GE 
Healthcare, Piscataway, NJ). Protein was eluted from the column using a linear gradient 
from 0 mM to 500 mM imidazole in 25 mM Tris, 150 mM NaCl, 10% glycerol (pH 7.4). 
Fractions containing active enzyme were pooled and dialyzed against buffer containing 
25 mM Tris, 150 mM NaCl, and 10% glycerol (pH 7.4). The enzymes were purified to 
apparent homogeneity as judged by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Protein concentration was quantified by the Bradford 
method [9] using the Bio-Rad Protein Assay with bovine serum albumin as standard.  
Determination of kinetic parameters for EhACK 
The hydroxamate assay [10-12] was used to determine kinetic parameters in the 
acetyl phosphate/Pi-forming direction as previously described using a reaction mixture 
containing 100 mM MES, 5 mM MgCl2, and 600 mM hydroxylamine hydrochloride (pH 
7.5) with the concentrations of acyl substrate and sodium pyrophosphate were varied. 
Reactions were performed at 45°C, the optimal temperature for this enzyme. Acetyl 
phosphate formation was determined by comparison to an acetyl phosphate standard 
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curve. All assays were performed in triplicate. Kinetic calculations and progress curves 
were generated using Kaleidagraph (Synergy Software, Reading, PA).   
Kinetic parameters in the acetate-forming direction of the reaction were 
determined using a modified reverse hydroxamate assay [13]. The reactions (300 µL) 
contained 100 mM Tris (pH 7.0), 10 mM MgCl2, and varying concentrations of sodium 
phosphate and acetyl phosphate. Reactions were pre-incubated for 1 minute at 37°C, 
initiated by the addition of purified enzyme or native E. histolytica extract and terminated 
by the addition of 50 µL 2 M hydroxylamine hydrochloride (pH 7.0). Following 
incubation at 60°C for 5 minutes, 100 µL 500 mM FeCl3, 3 N HCl, 30 % trichloroacetic 
acid or 500 mM FeCl3, 7 N HCl, 50 % trichloroacetic acid was added for color 
development and the absorbance at 540 nm was measured spectrophotometrically. All 
assays were performed in triplicate. A standard curve of acetyl phosphate concentrations 
was used to determine the amount of acetyl phosphate consumed in the reaction. 
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III. RESULTS AND DISCUSSION 
 
Production and purification of variant acetate kinases. 
Val87, Thr223, Ile116, Ser230, Ser271, Thr15, Thr201, Asp272, Arg274, His117, His172 and 
Glu323 in the E. histolytica ACK were subjected to site-specific replacement to test the 
hypothesis that these residues are involved in substrate binding and/or catalysis (Figure 
4.1). The residues selected were identified from multiple amino acid sequence alignments 
of ACKs from M. thermophila and other prokaryotic and eukaryotic microbes, and from 
preliminary E. histolytica structures and models. 
Kinetic characterization of putative acyl pocket residues. 
The most prominent difference between residues found in the acetate pocket of 
the well-characterized M. thermophila ACK to that of E. histolytica ACK is the presence 
of a threonine at position 223, corresponding to a proline at position 232 in the M. 
thermophila enzyme (Figure 4.1). Pro232 is involved in substrate positioning and catalysis 
in the acetate binding pocket of the M. thermophila ACK [14]. Alteration of Thr223 to 
proline for the E. histolytica ACK had little effect on the kinetic parameters as the 
enzyme remained capable of utilizing substrates as long as hexanoate (Table 4.1). 
Furthermore, kinetic parameters for PPi were also not significantly altered (Table 4.2). In 
the direction of acetate formation, no significant changes in the kinetic parameters for 
acetyl phosphate were observed for the Thr223Pro variant (Table 4.3). The Thr223Gly 
variant did not display activity for any acyl substrate in the acetyl phosphate-forming 
direction. A specific activity of 285.9 ± 0.1 µmol min-1 mg-1 was determined for the 
Thr223Gly variant in the acetate-forming direction at 0.6 mM acetyl phosphate in 
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comparison to the wild type specific activity of 1368.9 ± 0.1 µmol min-1 mg-1, but kinetic 
parameters could not be determined as the enzyme could not be saturated with 
pyrophosphate.  
Variant Thr223Ala was produced as an inactive and insoluble enzyme. Changes to 
this residue likely resulted in the addition of a side chain residue that disrupted proper 
folding of the enzyme. The Thr223Gly variant lacks a true side chain, and the resulting 
enzyme structure properly folded. 
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Figure 4.1. Sequence alignment of important residues in ACK from Eukarya, Bacteria, 
and Archaea. Residues that have been identified as being important for either acetate-
binding (red) or catalysis (blue) in the M. thermophila ACK are highlighted. Differences 
in the E. histolytica active site are noted in green. Residue numbers above the alignments 
are of E. histolytica ACK and  below the alignments are of M. thermophila ACK. 
Entamoeba histolytica, Ehistolytica; Entamoeba invadens, Einvadens; Phytophpthora 
ramorum, Pramorum; Phaeosphaeria nodorum, Pnodorum; Cryptococcus neoformans, 
Cneoformans; Escherichia coli, Ecoli; Methanosarcina thermophila, Mthermophila. 
 
 
 
            8 11  15             84 87 
Ehistolytica  1 MSNVLIFNVGSSSLTYKVF    81 FVGHRFVHGGS  
Einvadens   1 MPHILVFNVGSSSLTYKLF    81 IVGHRFVHGGS 
Pramorum  27 DSHLLVINAGSSSLKYSLF   115 AVGHRVVHGGE 
Pnodorum    2 SEIILSINAGSSSVKISVY    96 FTCHRVVHGGD 
Cneoformans  5 TEYLLAINCGSSSIKGKLF    96 YVCHRVVHGGT 
Ecoli   3 SKLVLVLNCGSSSLKFAII    87 AIGHRIVHGGE 
Mthermophila  1 -MKVLVINAGSSSLKYQLI    87 AVGHRVVHGGE  
            7  10  14             90 93 
 
         116/117               223      232  
Ehistolytica 112 PLAPIHNPSSF  216 DTSMGNSTLAGLVMSTRCGDID 
Einvadens  112 PLAPIHNPASY  216 DTSMGNSTLAGLVMSTRCGDID 
Pramorum  146 KLAPLHNPGNL  253 DTSMGMTPLEGLVMGTRSGDID 
Pnodorum  126 DLAPLHNGPAL  233 DTSMGLTPLAGLPGATRSGSID 
Cneoformans 129 EFAPLHNHRAV  237 DTSMGLTPLEGLLGGTRSGTID 
Ecoli  118 SFAPLHNPAHL  227 DTSMGLTPLEGLVIGTRSGDID 
Mthermophila 118 ELAPLHNPPNM  225 ETSMGFTPLEGLAMGTRCGSID 
         122/123               232      241  
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Table 4.1. Kinetic parameters for the wild type and Thr223Pro variant for acetate in the 
direction of acetyl phosphate synthesis. 
  Acetate 
Enzyme/Substrate  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type           
acetate  106.8 ± 1.00 1.8 ± 0.01 0.016 ± 0.001 
propionate  79.8 ± 1.94 1.2 ± 0.01 0.015 ± 0.001 
butyrate  75.6 ± 1.49 0.33 ± 0.01 0.0043 ± 0.0001 
valerate  56.7 ± 0.67 0.19 ± 0.01 0.0034 ± 0.0001 
hexanoate  20.5 ± 0.49 0.051 ± 0.001 0.0025 ± 0.0001 
           
Thr232 Pro           
acetate  169.5 ± 0.06 1.3 ± 0.01 0.23 ± 0.01 
propionate  98.7 ± 0.18 0.61 ± 0.01 0.0062 ± 0.0001 
butyrate  56.5 ± 0.46 0.18 ± 0.01 0.0032 ± 0.0001 
valerate  41.6 ± 0.25 0.21 ± 0.01 0.0049 ± 0.0001 
hexanoate  20.4 ± 0.52 0.065 ± 0.001 0.0032 ± 0.0001 
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Table 4.2. Kinetic parameters for the wild type and Thr223Pro variant for PPi in the 
direction of acetyl phosphate synthesis. 
  PPi 
Enzyme/Substrate  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type           
acetate  3.6 ± 0.1 3.9 ± 0.1 1.1 ± 0.02 
propionate  4.8 ± 0.4 2.6 ± 0.1 0.54 ± 0.02 
butyrate  3.2 ± 0.1 0.029 ± 0.001 0.09 ± 0.01 
valerate  6.3 ± 0.1 0.051 ± 0.001 0.081 ± 0.001 
hexanoate  16.3 ± 0.4 0.032 ± 0.001 0.019 ± 0.001 
           
Thr22 Pro           
acetate  6.3 ± 0.1 2.0 ± 0.01 0.32 ± 0.01 
propionate  4.0 ± 0.1 1.1 ± 0.01 0.17 ± 0.01 
butyrate  4.9 ± 0.1 0.73 ± 0.01 0.15 ± 0.01 
valerate  3.0 ± 0.1 0.29 ± 0.01 0.097 ± 0.001 
hexanoate  1.9 ± 0.1 0.081 ± 0.001 0.043 ± 0.001 
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Table 4.3. Kinetic parameters for acetyl phosphate for wild-type and variant ACKs 
assayed in the direction of acetate synthesis. 
  Acetyl phosphate 
Enzyme  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type  0.50 ± 0.006 1938.8 ± 13.7 3845.6 ± 68.9 
Thr223Pro  2.00 ± 0.082 8332.9 ± 185.4 4260.5 ± 82.7 
Thr223Gly  * * * 
Ile116Ala  1.6 ± 0.094 279.9 ± 2.0 174.9 ± 8.9 
Ile116Leu  2.4 ± 0.023 343.81 ± 2.1 143.8 ± 0.73 
Ser230Ala  4.5 ± 0.059 2181.0 ± 7.0 485.9 ± 5.1 
Ser230Gly  1.2 ± 0.038 1115.6 ± 10.0 911.3 ± 19.9 
Thr15Ala  1.1 ± 0.029 988.3 ± 9.5 896.1 ± 15.3 
Thr15Lys  1.1 ± 0.044 21.2 ± 0.25 19.0 ± 0.55 
Val87Ala  0.53 ± 0.027 120.8 ± 1.6 226.7 ± 10.1 
Val87Gly  0.51 ± 0.017 96.9 ± 0.96 188.7 ± 4.4 
Ser271Ala  1.0 ± 0.028 953.5 ± 6.6 916.0 ± 18.4 
Ser271Asn  0.58 ± 0.013 253.2 ± 0.87 436.5 ± 9.3 
Thr201Ala  1.7 ± 0.059 32.2 ± 0.29 18.5 ± 0.50 
Thr201Asn  1.2 ± 0.079 5.6 ± 0.06 4.6 ± 0.24 
Asp272Asn  0.71 ± 0.03 13.7 ± 0.13 19.3 ± 0.64 
Asp272Glu  * * * 
Asp272Ala  * * * 
Arg274Ala  0.56 ± 0.019 14.3 ± 0.13 25.9 ± 0.74 
His117Ala  8.0 ± 0.072 20.5 ± 0.07 2.6 ± 0.02 
His172Ala  0.69 ± 0.074 2.0 ± 0.07 2.8 ± 0.25 
* unable to determine kinetic parameters due to low activity 
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Although the E. histolytica ACK Thr223Ala variant was insoluble, an alanine change at 
the corresponding Pro232 residue in M. thermophila results in a soluble enzyme with a 
significantly decreased turnover (26-fold) and catalytic efficiency (126-fold) compared to 
the wild type [14]. This change in solubility of the enzyme for variant changes indicates a 
structural variation between these ACKs which is reinforced by these different residues. 
 In the M. thermophila ACK, a leucine is present at position 122 which 
corresponds to Ile116 in the E. histolytica ACK. Leu122 has been shown to play an 
important role in acetate binding [14] and is hypothesized to stabilize the methyl group of 
acetate in the M. thermophila ACK [15]. The Ile116Ala variant displayed insignificant 
changes in kinetics for acetate compared with the wild type kinetic parameters. However, 
the Ile116Leu variant displayed a 25-fold decrease in the kcat and 34-fold decrease in the 
overall enzyme efficiency for acetate compared to the wild type ACK (Table 4.4). Both 
the Ile116A and Ile116Leu variants were unable to utilize longer acyl substrates. A 26-fold 
decrease in kcat and 24-fold decrease in enzyme efficiency for PPi assayed with acetate 
were observed for the Ile116Ala variant (Table 4.5).  Kinetic parameters for PPi assayed 
with acetate could not be determined for the Ile116Leu variant due to low activity. 
Significant decreases for both the kcat and enzyme efficiency for acetate indicate that 
Ile116 plays an important for catalysis. In the direction of acetate formation, marked 
decreases of 22-fold and 27-fold in the catalytic efficiency were observed for both 
Ile116Ala and Ile116Leu respectively (Table 4.3). The decreases in catalytic efficiency for 
acetyl phosphate as well as the decreases in the turnover and catalytic efficiency in the 
acetate forming directions for these variants further implicates Ile116 as important for 
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catalysis. Whereas the Leu122 in the M. thermophila ACK plays a role in acetate binding, 
Ile116 in the E. histolytica enzyme has a role in catalysis. 
 Val87 in the E. histolytica ACK corresponds to Val93 in the M. thermophila ACK, 
which has been shown to be important for acetate binding [14] by providing stabilization 
to the methyl group of acetate [15]. The Val87Ala and Val87Gly variants were not active 
in the acetyl phosphate-forming directions and therefore kinetic parameters were unable 
to be determined. Loss of the more prevalent hydrophobic interaction indicates that this 
residue plays an important role in the active site of the E. histolytica ACK. Significant 
decreases in turnover and catalytic efficiency were observed for Val87Ala and Val87Gly in 
the direction of acetate synthesis (Table 4.3). 91-fold and 16-fold decreases in turnover 
and 202-fold and 16-fold decreases in catalytic efficiency were observed for Val87Ala and 
Val87Gly respectively. These significant decreases in the direction of acetate synthesis 
indicate that Val87 plays an important role in catalysis. Val87 is located in a hydrophobic 
pocket of the putative active site with another hydrophobic residue (Phe117) at a distance 
of only 4.3 Å. These residues may also participate in hydrophobic interactions with the 
methyl group of acetate and acetyl phosphate in the E. histolytica ACK. 
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Table 4.4. Kinetic parameters for acetate for wild-type and variant ACKs assayed in the 
direction of acetyl phosphate synthesis. 
  Acetate 
Enzyme  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type  106.8 ± 1 1.8 ± 0.01 0.016 ± 0.001 
Ile116Ala  219.6 ± 9.9 0.88 ± 0.01 0.004 ± 0.001 
Ile116Leu  146.2 ± 5.3 0.069 ± 0.001 0.00047 ± 0.00001 
Ser230Ala  142.6 ± 9.8 0.84 ± 0.013 0.0059 ± 0.0003 
Ser230Gly  145.9 ± 1.7 0.57 ± 0.001 0.0039 ± 0.0001 
Thr15Lys  59.1 ± 6.6 0.27 ± 0.001 0.0045 ± 0.0001 
Thr15Ala  114.0 ± 0.85 0.61 ± 0.001 0.0054 ± 0.0001 
Ser271Asn  140.3 ± 2.8 0.16 ± 0.001 0.0012 ± 0.0001 
Arg274Ala  186.4 ± 21.7 0.11 ± 0.003 0.00056 ± 0.00005 
Ser271Ala  173.7 ± 0.92 0.93 ± 0.01 0.0054 ± 0.0001 
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Table 4.5. Kinetic parameters for PPi for wild-type and variant ACKs assayed in the 
direction of acetyl phosphate synthesis in the presence of acetate. 
  PPi 
Enzyme  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type  3.9 ± 0.1 3.6 ± 0.1 1.1 ± 0.02 
Ile116Ala  0.2 ± 0.01 3.3 ± 0.1 0.043 ± 0.001 
Ser230Ala  1.1 ± 0.01 1.4 ± 0.1 0.78 ± 0.01 
Ser230Gly  1.2 ± 0.01 5.2 ± 0.1 0.23 ± 0.01 
Thr15Ala  0.73 ± 0.01 3.3 ± 0.1 0.22 ± 0.01 
Ser271Asn  0.22 ± 0.01 1.1 ± 0.1 0.20 ± 0.01 
Arg274Ala  0.23 ± 0.01 2.8 ± 0.1 0.085 ± 0.001 
Ser271Ala  1.3 ± 0.01 5.7 ± 0.1 0.22 ± 0.01 
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Characterization of other catalytically important residues. 
A lysine at position 14 in the M. thermophila ACK has been shown to be 
catalytically important in the active site, acting as a site for hydrogen bonding during 
substrate interaction [14]. Lys14 corresponds to Thr15 in the E. histolytica enzyme. With 
acetate as the acyl substrate, alteration of Thr15 to alanine resulted in a 12-fold increase in 
kcat, but did not significantly alter other kinetic parameters (Table 4.4). Kinetic 
parameters for propionate were not significantly altered (Table 4.6), but information on 
longer acyl chain substrates could not be garnered due to loss of activity. No significant 
changes in the kinetic parameters for acetyl phosphate were observed for the Thr15Ala 
variant in the acetate forming direction. However, 91-fold and 202-fold decreases in 
turnover and catalytic efficiency of acetyl phosphate were observed for the Thr15Lys 
variant in the direction of acetate synthesis (Table 4.3).  
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Table 4.6. Kinetic parameters for propionate for wild-type and variant ACKs assayed in 
the direction of acetyl phosphate synthesis. 
  Propionate 
Enzyme  Km (mM) kcat (s-1) kcat/Km (s-1 mM-1) 
wild type 
 
79.8 ± 1.94 1.2 ± 0.005 0.015 ± 0.0003 
Thr223Pro 
 
98.7 ± 0.18 0.61 ± 0.001 0.0062 ± 0.00001 
Ser230Ala 
 
104.4 ± 4.19 0.36 ± 0.003 0.0034 ± 0.0001 
Ser230Gly 
 
128.4 ± 0.05 0.36 ± 0.001 0.0028 ± 0.00001 
Thr15Ala 
 
108.8 ± 0.98 0.26 ± 0.001 0.0024 ± 0.00002 
Ser271Asn 
 
64.4 ± 0.82 0.058 ± 0.001 0.00091 ± 0.00001 
Ser271Ala 
 
101.5 ± 0.60 0.33 ± 0.0002 0.0032 ± 0.00002 
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The change in observed kinetic parameters as compared to those of the 
corresponding Lys14 residue in the M. thermophila enzyme, imply that Thr15 in the E. 
histolytica ACK may have a different role from its archaeal Lys14 counterpart. 
Theoretically, the Thr15Lys variant would result in lysine protruding into the core of the 
putative active site, likely interfering with catalysis (Figure 4.2). The Thr15 residue is 
located on the periphery of the putative active site and likely plays a role in catalysis 
upon close of the active site.  
In the M. thermophila ACK, His180 plays an important role in catalysis [16], and 
is hypothesized to interact with the α-phosphate of ATP during acetyl phosphate 
synthesis by stabilizing the transition state [15]. When the corresponding residue in E. 
histolytica (His172) was altered to alanine activity in the acetyl phosphate-forming 
direction could not be detected. In the direction of acetate formation a 995-fold and 1354-
fold decrease in respective turnover and catalytic efficiency for acetyl phosphate was 
observed for His172Ala (Table 4.3). This significant decrease in turnover and enzyme 
efficiency indicates that this residue is critical for catalysis. The His172 residue lies 
directly in the core of the active site, providing one or more hydrogen atoms from the 
imidazole ring of histidine as lone pair acceptors. Alteration of this residue to alanine 
would theoretically remove this residue from the core of the putative active site, 
providing only limited, if any, hydrophobic interaction with the substrates. 
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Figure 4.2. The putative active site of the E. histolytica ACK. Residues important for 
acetate binding and catalysis (turquoise). Residues that may interact with substrates upon 
closure of the active site (red). The putative active site is modeled from data received 
from the laboratory of Dr. Tina Iverson, Vanderbilt University [6]. 
 
 
 
 
 
150 
 
His123 is located near the active site in the M. thermophila ACK and has been 
reported to be important for acetyl phosphate binding [16]. When the corresponding 
His117 in the E. histolytica enzyme was changed to alanine, acetyl phosphate synthesis 
could not be detected. In the direction of acetate synthesis the His117Ala variant displayed 
a 16-fold increase in the Km for acetyl phosphate, indicating that this residue may be 
important for acetyl phosphate binding (Table 4.3). Furthermore, a 95-fold and 1496-fold 
decrease in respective turnover and catalytic efficiency for acetyl phosphate was 
observed for His117Ala. This significant decrease implicates this residue‘s importance in 
catalysis. This residue lies near the core of the putative active site (Figure 4.2), and like 
His172, may provide hydrogen atoms for electrons from an oxygen located one or more of 
the phosphate groups of Pi or PPi. The His117Ala variant would result in removal of these 
lone pair acceptors and the resulting methyl group side chain would likely be so far 
removed from the core of the putative active site that interaction with ACK substrates 
would no longer be possible. 
Characterization of other possible active site residues. 
The E. histolytica ACK was crystallized in the presence of PPi and an electron 
density found to be present within the structure was originally modeled as PPi (Figure 
4.3). However, further refinement suggests that PPi is not present in the structure. 
Residues Ser230, Ser271, Asp272, Arg274, and Thr201 were hypothesized to participate in PPi 
binding and/or catalysis in the initial structure. Protein sequence alignments comparing 
the corresponding residues in the M. thermophila, E. coli, and fungal ACK sequences 
indicate a number of these changes are unique to the Entamoeba enzymes (Figure 4.4).  
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Figure 4.3. An early model of the active site of the E. histolytica ACK. Residues Ser230, 
Ser271, Asp272, Arg274, and Thr201 are hypothesized to participate in PPi binding and/or 
catalysis. Structure image produced by Tarjani Thaker and Dr. Tina Iverson, Vanderbilt 
University. 
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To investigate the roles of these residues in the E. histolytica ACK, each of the above 
residues was changed to either alanine or the corresponding amino acid found in the M. 
thermophila ACK. 
 Ser230Ala and Ser230Gly variants did not display significant changes in kinetic 
parameters for acetate (Table 4.4), or PPi (Table 4.5), or propionate (Table 4.6). 
However, parameters for longer acyl chain substrates could not be determined due to loss 
of activity.  No significant changes in the kinetic parameters for acetyl phosphate were 
observed for either variant. 
Another serine residue (Ser271) is located adjacent to Ser230 in the putative active 
site (Figure 4.4). Variants Ser271Ala and Ser271Asn had insignificant changes in their 
kinetic parameters for acetate with exception to Ser271Asn which displayed a 10-fold 
decrease in enzyme efficiency in acetyl phosphate synthesis (Table 4.4). A 17-fold 
decrease in the kcat for PPi was observed for acetyl phosphate synthesis (Table 4.5). Both 
Ser271Ala and Ser271Asn were unable to utilize acyl substrates longer than propionate. A 
30-fold decrease in the kcat and 17-fold decrease in enzyme efficiency was observed for 
Ser271Asn for propionyl phosphate synthesis (Table 4.6). No significant changes in 
kinetic parameters were observed for Ser271Ala and Ser271Asn in the direction of acetate 
synthesis.  
In the refined structure, Ser230 and Ser271 are located on the margins of the 
putative active site and would appear to have little to no interaction with acetyl phosphate 
(Figure 4.2). However, changes to these residues had an effect on propionate and longer 
acyl substrates during acetate synthesis. The absence of activity of substrates longer than 
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propionate can be attributed to the use of high concentrations of protein in the assay to 
detect ACK activity in the direction of acetate synthesis. The use of such high 
concentrations of protein is necessary for the detection of ACK activity in this direction 
and is likely the reason that Reeves and Guthrie [5] were unable to detect acetyl 
phosphate forming ACK activity more than 35 years earlier. 
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Figure 4.4. Alignment of sequences identified from early analysis of the E. histolytica 
structure along with corresponding residues from other Eukarya, Bacteria, and Archaea. 
Residues proposed to play a role in either ATP binding and catalysis in the M. 
thermophila ACK are highlighted in green. Active site residue differences in the 
Entamoeba ACKs (blue) and fungal ACKs (red) are noted. Residue numbers above the 
alignments are of the E. histolytica ACK. Residue numbers below the alignments are of 
the M. thermophila ACK. Entamoeba histolytica, Ehistolytica; Entamoeba invadens, 
Einvadens; Phytophpthora ramorum, Pramorum; Phaeosphaeria nodorum, Pnordorum; 
Cryptococcus neoformans, Cneoformans; Escherichia coli, Ecoli; Methanosarcina 
thermophila, Mthermophila. 
 
 
198 201           230 
Ehistolytica  195 IACHLGTGGSS  226 GLVMSTRCGDID 
Einvadens     195 VACHLGTGGSS  226 GLVMSTRCGDID 
Pramorum      233 VTCHLGNG-SS  263 GLVMGTRSGDID 
Pnodorum      213 VALHLGSG-AS  243 GLPGATRSGSID 
Cneoformans   217 VVAHLGSG-SS  247 GLLGGTRSGTID 
Ecoli         207 ITCHLGNG-GS  237 GLVIGTRSGDID 
Mthermophila  205 ITCHLGNG-SS  235 GLAMGTRCGSID 
208 211            239 
 
                271/272/274       323 327 
Ehistolytica  270 SSDMRDILH   320 FTDQMGLEVWQV 
Einvadens     270 SCDIRDLLK   320 FTDQVGLEVPEV 
Pramorum      308 ESDIRVIQD   357 FTAGIGESSAMI 
Pnodorum      298 TTDFGKISS   342 FAGGIGEKGDRL 
Cneoformans   299 TTNFGHIIQ   358 FSGGIGEKGAEL 
Ecoli         283 TSDCRYVED   330 FTGGIGENAAMV 
Mthermophila  281 SNDFRDLDE   328 FTAGIGENSASI 
                282/283/285        331 335 
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Thr201 in the E. histolytica ACK was altered to alanine and asparagine. Both the 
Thr201Ala and Thr201Asn variants were not active in the acetyl phosphate-forming 
direction indicating that these residues may play an important role in the active site. In 
the direction of acetate synthesis, significant decreases in both the kcat and catalytic 
efficiency for acetyl phosphate were observed for both variants. A 60-fold and 343-fold 
decrease in the kcat were observed for Thr201Ala and Thr201Asn respectively (Table 4.3). 
Decreases of 207-fold and 837-fold in catalytic efficiency were respectively observed for 
Thr201Ala and Thr201Asn. These significant decreases in both enzyme turnover and 
catalytic efficiency for acetyl phosphate indicate that this residue plays an important role 
in catalysis, most especially in the direction of acetate formation. Thr201 projects the 
methyl group of the side chain into the core of the putative active site; which leads to the 
hypothesis that this residue may provide some hydrophobic interaction during catalysis 
(Figure 4.2). The Thr201Ala variant contains a truncated side chain in comparison to the 
wild type enzyme, reducing the hydrophobic interaction in this region of the putative 
active site, and would theoretically point in a direction perpendicular to the direction of 
the methyl group of threonine at this position. Thr201Asn variant alters the 
hydrophobicity, and likely ejects a polar side chain into the putative active site. The 
significant decreases in both catalysis and catalytic efficiency noted above for the 
Thr201Asn variant, but less significant for the Thr201Ala variant support the presence of a 
hydrophobic side chain interacting with one or more of the substrates utilized by the 
enzyme. Thr201 could also participate in hydrogen bonding with one or more of the ACK 
substrates. 
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 Asp272 was altered to asparagine, glycine, and alanine. The variants were not 
active in the acetyl phosphate-forming direction indicating that this residue may be 
important for acetate and/or PPi binding or catalysis. Furthermore, the Asp272Asn variant 
displayed significant decreases of 142-fold and 200-fold turnover and catalytic efficiency 
for acetyl phosphate in the direction of acetate formation (Table 4.3). Aspartate variants 
Asp272Asn and Asp272Gly displayed specific activities too low to determine kinetics. The 
significant decreases in turnover and catalytic efficiency for the Asp272Asn variant and 
extremely low specific activity for Asp272Ala and Asp272Gly in the direction of acetate 
synthesis implies that this residue plays an important role in catalysis. This residue may 
be important in enzyme folding or in structural integrity of the putative active site. The 
aspartate residue faces away from the internal portion of the putative active site, and 
therefore, would not be hypothesized to participate in substrate interaction (Figure 4.2). 
In the M. thermophila ACK, Arg285 is involved in binding acetate [17] and the 
corresponding residue Arg274 is also near putative acetate pocket in the E. histolytica 
active site. An Arg274Ala variant displayed a 16-fold and 17-fold decrease in kcat for 
acetate (Table 4.4) and PPi respectively (Table 4.5). The enzyme efficiencies for acetate 
and PPi were also decreased by 28-fold and 12-fold, respectively. The Arg274Ala variant 
was unable to use longer acyl substrates. In the direction of acetate synthesis a 135-fold 
and 148-fold decrease in respective turnover and catalytic efficiency were observed for 
acetyl phosphate (Table 4.3), implying that this residue may be important for catalysis. 
The decreases observed in the acetyl phosphate forming direction for PPi combined with 
the decreases observed in the kinetic parameters for acetyl phosphate in acetate synthesis 
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highlights that this residue may interact with one or more of the phosphates of PPi and/or 
acetyl phosphate. One, if not both of the amine groups of Arg274 face into the active site, 
allowing for one or more of the hydrogen atoms a part of the amine to act as a lone pair 
acceptor (Figure 4.2). The truncated side chain in the Arg274Ala variant would be 
hypothesized to no longer interact with substrates in the putative active site due to 
distance from the site core. While, Arg285 in the M. thermophila ACK plays a role in 
acetate-binding, the corresponding Arg274 residue in the E. histolytica enzyme is involved 
in catalysis. 
Conclusions. 
 Kinetic analyses of ACKs variants identified from sequence alignments have 
resulted in the identification of residues important for acetate and acetyl phosphate 
binding, and catalysis. Furthermore, a number of residues that may be important for PPi-
binding have also been identified.  
Multiple attempts were made to generate variants of Glu323, but site specific 
changes could not be generated at the DNA level possibly due to primer interactions or 
temperature annealing problems. 
 While a number of important residues have been identified, additional residues 
that have been identified in both sequence alignments (Figure 4.1 and Figure 4.3) and in 
recent refined structures [6] should be further investigated. Ser11, Ser12, Ser13, and Asn8 
are located in the margins of the putative active site and may provide sites for interaction 
with phosphate oxygen atoms. His198 and Arg232 protrude into the core of the putative 
active site, and their close proximity to other residues that have been shown to be 
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important in catalysis implicates them as candidates for site specific changes. The results 
presented here have not only broadened our understanding of the ACK enzyme family 
but have provided a foundation for future investigations. 
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CHAPTER V 
RNA INTERFERENCE AND THE PHYSIOLOGICAL ROLE OF THE 
ACETATE KINASE IN ENTAMOEBA HISTOLYTICA 
 
Matthew L. Fowler, Madison A. Foster, Ann M. Guggisberg, Cheryl J. Ingram-
Smith, and Kerry S. Smith 
 
ABSTRACT 
Entamoeba histolytica is a protozoan parasite and the third leading cause of 
parasitic morbidity and mortality worldwide. The enzyme acetate kinase (ACK), a 
prokaryotic metabolic enzyme, has recently been discovered in several eukaryotic 
organisms, including E. histolytica. In prokaryotes, ACK catalyzes the reversible 
phosphorylation of acetate to acetyl phosphate utilizing ATP. The ACK identified in E. 
histolytica differs from the prokaryotic ACK in that the enzyme uses pyrophosphate (PPi) 
in place of ATP as the phosphoryl donor. Common partners for ACK, 
phosphotransacetylase (PTA) and xylulose 5-phosphate/fructose 6-phosphate 
phosphoketolase (XFP) are also absent in the current E. histolytica genome assembly. 
Here, the dependency of the PPi-dependent ACK from E. histolytica is investigated. Short 
hairpin RNA interference constructs were generated in order to post-transcriptionally 
knock down the expression of the E. histolytica PPi-ACK. Specific activities from 
purified E. histolytica extracts indicate that the enzyme functions in the direction of 
acetyl phosphate formation, suggesting a physiological means of generating PPi. The 
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introduction of plasmid DNA into E. histolytica was unsuccessful in these experiments. 
However, the results here will be important for future attempts at gene knockdown and 
investigations into parasite dependency on this enzyme. Further knowledge of the 
dependency of metabolic enzymes in E. histolytica may lead to new drug targets and 
treatments of amoebic dysentery. 
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I. INTRODUCTION 
Entamoeba histolytica is a protozoan parasite and the causative agent of amoebic 
dysentery. Affecting nearly 50 million people worldwide, E. histolytica is the third 
leading cause of death world-wide due to parasitic disease resulting in more than 100,000 
deaths annually [1]. Infection of the host is accomplished through the fecal-oral route. 
Contaminated food or water is ingested which contain quadra-nuclear cysts. Once these 
cysts reach the lumen of the small intestine, the cysts undergo excystation, resulting in 
the production of the amoebic trophozoites. These mobile parasites can then disseminate 
to other organs such as the liver, lungs, or brain and generate abscesses which result in a 
high rate of mortality [2]. Trophozoites can undergo encystation in the large intestine 
where they are passed into the feces (Figure 5.1) [3]. 
Initially thought to be present only in prokaryotes, ACK has been identified in the 
genomes of several eukaryotes, including E. histolytica [4]. ACK functions in the 
interconversion of acetate to acetyl phosphate with ATP as the phosphoryl donor and is 
an important enzyme in bacterial and archaeal metabolism for the synthesis of acetyl-
CoA [4-6]. In many prokaryotes, and more recently discovered in eukaryotes such as 
Phytophthora spp. and Chlamydomonas reinhardtii, a partner enzyme 
phosphotransacetylase (PTA) is responsible for the interconversion of acetyl phosphate to 
acetyl-CoA[4]. In fungi, another bacterial enzyme xylulose 5-phosphate/fructose 6-
phosphate phosphoketolase (XFP), has been proposed to partner with ACK to convert 
xylulose 5-phosphate or fructose 6-phosphate to acetate for the generation of ATP [4]. 
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Figure 5.1. Life cycle of E. histolytica. The mature cyst is ingested by the human host.  
Excystation of the cyst occurs in the small intestine where the active trophozoite is 
produced.  The trophozoite can then replicate by binary fission to form additional 
trophozoites, or can undergo encystation to produce a number of cysts.  Cysts are passed 
into the host’s feces where water-borne transmission allows for continuation of the 
parasite’s life cycle. Taken from [3]. 
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Previous research on E. histolytica  has led to the discovery of an ACK in the 
parasite [7]. The enzyme is novel among other known ACKs in that the enzyme utilizes 
PPi as the phosphoryl donor in the place of ATP [8]. Furthermore, this ACK is unique in 
that it is capable of utilizing acyl substrates longer than butyrate. [8]. The enzyme 
displays 3,500-fold difference in catalytic efficiency in the direction of acetate formation 
indicating preferential directionality for acetate and PPi formation. Acetyl phosphate 
could be generated from either XFP or PTA, partners for ACK in other eukaryotes. 
However, genes encoding either enzyme are absent in the most recent genome assembly. 
We are currently investigating the role of the PPi-dependent ACK in E. 
histolytica. An acetate-forming PPi-ACK activity was detected in cellular extracts, but an 
ATP-ACK activity was not.  Activities for PTA and XFP, the proposed partners for ACK 
in other eukaryotes, were also not detected in cellular extracts of the parasite. Here we 
describe an attempt at short hairpin RNA (shRNA) interference in E. histolytica in order 
to down-regulate expression of the enzyme. The introduction of shRNAs into the parasite 
is expected to target and inhibit expression of the ACK. While we were unable to 
successfully perform this technique as previously described [9, 10], the results of RNAi 
experiments are important for the future development of this system and determination of 
the importance of this enzyme in the parasite’s metabolic processes. In addition, the 
human host lacks an ACK, implicating this gene as a possible target for the development 
of new treatments for infection by E. histolytica. 
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II. MATERIAL AND METHODS 
Cultivation of E. histolytica 
Trophozoites of E. histolytica strain HM1:IMSS were routinely cultured under 
axenic conditions in TYI-S-33 medium [11]. 
 Cell extract preparation 
To prepare E. histolytica cell extracts, 4 x 106 trophozoites were resuspended in 
25 mM Tris, 150 mM NaCl (pH 7.4) and vortexed with acid-washed glass beads for one 
minute followed by one minute on ice, for three cycles. The extract was centrifuged at 
5000 x g for 15 minutes and the supernatant isolated. 
Hydroxamate assay for ACK activity 
The hydroxamate assay [5, 12, 13] was used to determine kinetic parameters in 
the acyl phosphate-forming direction.  The reactions (300 µL) contained 100 mM MES, 5 
mM MgCl2, 600 mM hydroxylamine hydrochloride (pH 7.5), 2 M acetate and 10 mM 
sodium pyrophosphate.  ATP and PPi were tested as substrates at a final concentration of 
10 mM. The reactions were pre-incubated at 45°C for 1 minute and initiated by the 
addition of enzyme.  Reactions were terminated by the addition of two volumes of 1.25% 
FeCl3, 1 N HCl, 5% trichloroacetic acid and the absorbance at 540 nm was measured 
spectrophotometrically.  All assays were performed in triplicate. Kinetic calculations and 
progress curves were generated using Kaleidagraph (Synergy Software, Reading, PA).   
Kinetic parameters in the acetate-forming direction of the reaction were 
determined using a modified reverse hydroxamate assay [14].  The reactions (300 µL) 
contained 100 mM Tris (pH 7.0), 10 mM MgCl2, 200 mM sodium phosphate, and 2 mM 
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acetyl phosphate.  Reactions were pre-incubated for 1 minute at 37°C, initiated by the 
addition of purified enzyme or native E. histolytica extract and terminated by the addition 
of 50 µL 2 M hydroxylamine hydrochloride (pH 7.0). Following incubation at 60°C for 5 
minutes, 100 µL 250 mM FeCl3, 1.5 N HCl, 15 % trichloroacetic acid was added for 
color development and the absorbance at 540 nm was measured spectrophotometrically.  
All assays were performed in triplicate. A standard curve of acetyl phosphate 
concentrations was used to determine the amount of acetyl phosphate depleted in the 
reaction. 
Phosphotransacetylase (PTA) assay 
Activity was measured in both the acetyl phosphate-forming and the acetyl-CoA-
forming directions by monitoring the decrease or increase in absorbance at 233 nm for 20 
minutes in triplicate, indicative of the formation or breakage of the thioester bond of 
acetyl-CoA, respectively.  The reaction mix for the acetyl phosphate-forming assay [6] 
consisted of 100 mM Tris (pH 7.0), 2 mM DTT, 10 mM sodium phosphate, and 120 µg 
of native E. histolytica extract in a total volume of 200 µL. The reaction was initiated by 
the addition of acetyl-CoA (0.5 mM final concentration).  The reaction mix for the acetyl-
CoA-forming assay consisted of 100 mM Tris (pH 7.0), 2 mM DTT, 0.5 mM CoA, and 
120 µg of native E. histolytica extract in a total volume of 200 µL. The reaction was 
initiated by the addition of acetyl phosphate (2 mM final concentration).   
Xylulose 5-phosphate/fructose 6-phosphate phosphoketolase (XFP) assay 
XFP activity in E. histolytica cell extracts was analyzed using the hydroxamate 
assay to detect the formation of acetyl phosphate [5, 12, 13].  The reaction mix contained 
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100 mM Tris, 600 mM hydroxylamine hydrochloride, 2 mM DTT, and 100 mM fructose 
6-phosphate (pH 7.0) in a total volume of 300 µL.  The reaction was initiated by the 
addition of 120 µg of native E. histolytica extract and terminated after 30 minutes by the 
addition of 2 volumes of 1.25% FeCl3, 1 N HCl, 5% trichloroacetic acid.  Product 
formation was determined by the change in absorbance at 540 nm and comparison to an 
acetyl phosphate standard curve.  All assays were performed in triplicate. 
Short hairpin RNA interference constructs 
In order to knock down the expression of the ACK gene in E. histolytica via RNA 
interference (RNAi), constructs were made using a two-step PCR procedure (Figure 
5.2A) [10]. Constructs form short hairpin RNAs (shRNAs), each composed of a 29 base 
sense strand, a 9 base loop, and a 29 base antisense strand (Figure 5.2C). To generate 
shRNAs against the EhACK gene, four sequences were selected from the E. histolytica 
ACK gene sequence using the siRNA target finder at 
http://www.ambion.com/techlib/misc/siRNA_finder.html. Each sequence was denoted 
according to its starting nucleotide position (441, 462, 600, and 842) within the EhACK 
gene sequence. Chosen sequences contained 21 nucleotides, beginning with AA and 
possessing GC content between 30 and 50 percent. A 29 nucleotide sequence was 
generated by the addition of 8 nucleotides from the EhACK gene sequence by addition to 
each 21 nucleotide sequence. A scrambled negative control sequence was generated by 
inputting the experimental construct 441 sequence into a word scrambler 
(http://www.lerfjhax.com/scrambler) to jumble the sequences. The scrambled control 
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along with the other 29 nucleotide shDNA sequences were blasted against the E. 
histolytica genome to ensure that there were no possible off-target effects.  
 The reverse primers for each round of PCR were designed using the reverse 
complements of the desired constructs (Table 5.1). The reverse primer for the first round 
of PCR contained the reverse complement of the 3’ end of the E. histolytica U6 promoter 
(GGATAAAAAGAAAAATAAAATT), the ApaI site (GGGCCC), the sense strand of 
the 29-mer shRNA sequence chosen with the siRNA target finder, and the 9 base loop 
(TTCAAGAGA). The reverse primer for the second round of PCR contained the reverse 
complement of the 9 base loop, the antisense strand of the shRNA sequence, the T6 
terminator (TTTTTT), and the NotI site (GCGGCCGC). Because the shRNA sequence 
ends in TT, only TTTT was inserted as the T6 terminator. Additionally, the reverse 
complement of GATCGA was added to the end of the sequence to allow for optimal NotI 
digestion. 
 The first round of PCR was conducted using KOD Hot Start DNA polymerase 
(EMD Chemicals), along with the U6 HindIII forward primer 
(CTACTGAAGCTTGTTTTTATGAAAAAGTGTATTTGC, 10 µM) and the first round 
reverse primers (10 µM) (Table 5.1). pGIR310:U6 + PATscram (45µg/ml) plasmid 
(kindly provided by Dr. William Petri [10]), containing the RNA polymerase III U6 
promoter originally cloned from E. histolytica genomic DNA was used as the template. 
Two 50 µl reactions were performed for each shRNA construct using 2 µl and 5 µl of 
plasmid template, respectively, and the published PCR conditions [10]. Round 1 PCR 
products were confirmed by gel electrophoresis. 
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The second round of PCR was conducted using KOD Hot Start DNA polymerase, 
along with the U6 HindIII forward primer (10 µM) and the second round reverse primers 
(10 µM) (Table 5.1). Two 50 µl reactions were performed for each shRNA construct 
using 2 µl of the respective Round 1 PCR products as the template and the published 
PCR conditions [10]. Final PCR products from Round 2 were confirmed by gel 
electrophoresis. 
Final PCR products were purified used the Wizard SV PCR Clean-Up System 
(Promega) and digested separately in two consecutive reactions with HindIII and NotI, 
along with expression vector pGIR310: EV+PL (also known as pGIR310 2.1.2) an empty 
vector pGIR310 modified with a HindIII-SalI-NotI-HindIII polylinker. After gel-
purification of the digested products, the RNAi construct inserts were directly cloned into 
pGIR310: EV+PL between the HindIII and NotI sites of the polylinker using Novagen 2x 
clonables (EMD Chemicals) (Figure 5.2B). 
 Recombinant plasmids were transformed into NovaBlue competent E. coli cells 
(Novagen, Inc.) and plated on LB-ampicillin plates. Proper ligation was confirmed by 
PCR colony screen using the conditions described in the creation of shDNA sequences.  
Transformed colonies were grown up into LB-ampicillin medium, and the recombinant 
plasmids purified using the Zyppy Plasmid Miniprep Kit (Zymo Research Corporation). 
Purified plasmids were digested with HindIII and NotI and run on an agarose gel for 
further verification of proper RNAi construct insertion into pGIR310. Confirmed clones 
were sequenced using the Sp6 forward primer and the hgl reverse primer by the Clemson 
University Genomics Institute. Recombinant plasmids verified by sequencing to contain 
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the correct shRNAi construct were produced and purified on a large-scale using Zyppy 
Plasmid Maxiprep Kit (Zymo Research Corporation) or the Plasmids Mega Prep Kit 
(Qiagen, Inc.). 
Control Transfection Plasmids 
The pGIR308 and pGIR209 plasmids were obtained from the laboratory of Dr. 
Lesly Temesvari at Clemson University. These plasmids are used as part of a tetracycline 
inducible system often used to express or over express modified proteins in E. histolytica. 
The plasmid were obtained and transformed into NovaBlue (Novagen, Inc.) E. coli cells. 
Plasmid was purified using a Plasmid Mega Prep Kit (Qiagen, Inc.). 
Transfection of E. histolytica 
Two separate methods of transfecting E. histolytica cells were utilized. For 
electroporation cells were cultivated as described above. Cells grown to confluence were 
washed twice using ice-cold phosphate buffered saline, and washed once with ice-cold 
Cytomix (120 mM potassium chloride, 0.15 mM calcium chloride, 10 mM potassium 
phosphate, 25 mM HEPES, 2 mM EGTA, 5 mM magnesium chloride, pH 7.6) [15]. The 
cells were resuspended to a concentration of 1 x 106 cells/800 µL in freshly generated 
Cytomix-AG (Cytomix containing 4 mM ATP and 10 mM glutathione). 1 x 106 cells 
were placed in a 4 mm electroporation cuvette along with 200 µL of sterile water for 
controls, or 60-80 µg of prepped plasmid RNAi constructs and pulsed twice at 1200 volts 
+ 25 µFD using a Gene Pulser Xcell Total System, Model No. 165-2660 (BioRad, Inc.) 
Time constants of 0.3-0.6 msec were routinely observed. The cells were immediately 
returned to 50 mL sterile cell culture flasks containing pre-warmed media. The cells were 
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incubated at 37°C in a water-jacketed incubator. Hygromycin or G418 were added at 
concentration of 5-15 µg/mL and 3-6 µg/mL respectively where indicated after 24-72 
hours.  
For the alternative method of transformation, cells were cultivated as described 
above. Cells grown to confluence were washed twice with phosphate buffered saline and 
resuspended to a concentration of 1 x 106 cells/mL. 15 µL of Superfect® (Qiagen, Inc.) 
reagent was added to 20-40 µg of plasmid and incubated at ambient temperature for 5-10 
minutes to allow transformation complexes to form. The Superfect®-plasmid complex 
added to either microcentrifuge tubes or 5 mL sterile glass vials along with 1 x 106 cells 
and incubated horizontally at 37°C for 3-4 hours. Following the incubation, cells were 
returned to 50 mL sterile flasks containing pre-warmed media and incubated at 37°C. 
Antibiotics were added at concentration described above after 24-72 hours. 
Generation of a hygromycin killing curve 
 1 x 106 cells were inoculated into 50 mL sterile flasks containing pre-warmed 
media. Hygromycin was added at concentrations of 0, 2.5, 5, 10, 15, and 20 µg/mL in 
equivalent volumes and incubated at 37°C.  The cells were counted by light microscopy 
using a hemocytometer every 24 hours over a period of 4 days. The data representing 
cells counted after 48 hours was transformed to percent cells surviving and a smooth, 
second order regression curve was generated using Kaleidagraph (Synergy Software). 
Manual interpolation was used to determine the LD50. 
Chemicals 
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Chemicals were obtained from Sigma-Aldrich, ThermoFisher Scientific, or VWR 
Scientific Products. 
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Table 5.1. Reverse primer sequences to create shRNAi constructs. 
EhACK 
sequence 
Round 1 of PCR 
 
Round 2 of PCR 
 
 
 
441 
TCTCTTGAACGTATGTTCTTTCTG
CTTGTGAGATGGTTGGGCCCAAT
TTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAACCA
TCTCACAAGCAGAAAGAACATAG
CTCTCTTGAA 
 
 
462 
TCTCTTGAATTTGGTAAGGTTGT
GGAATAGCGTATGTTGGGCCCAA
TTTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAACAT
ACGCTATTCCACAACCTTACCAA
ATCTCTTGAA 
 
 
600 
TCTCTTGAACAATGCCACAACAA
CTAGAACCACTCGTTGGGCCCAA
TTTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAACAG
GTGGTTCTAGTTGTTGTGGCATTG
TCTCTTGAA 
 
 
842 
TCTCTTGAAACATGTTTTAGCTTT
TGGACCTCTAGTTTGGGCCCAAT
TTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAAACT
AGAGGTCCAAAAGCTAAAACATG
TTCTCTTGAA 
 
Scrambled 
control 
TCTCTTGAAGCTTCGTTATCTTCG
GTGTGATTGATGTTGGGCCCAAT
TTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAACAT
CAATCACACCGAAGATAACGAAG
CTCTCTTGAA 
New 
scrambled 
control 
TCTCTTGAATATATTTATTTACCG
TTGAGTGGCCCTTTGGGCCCAAT
TTTATTTTTCTTTTTATCC 
TCGATCGCGGCCGCAAAAAAAGG
GCCACTCAACGGTAAATAAATAT
ATCTCTTGAA 
 
176 
 
 
177 
 
Figure 5.2. shRNA system for Entamoeba histolytica. (A) Diagram of the two-step PCR 
process for generating short hairpins shRNA constructs. Genomic DNA (or subsequently, 
the cloned U6 promoter) was used as a template to amplify the E. histolytica U6 promoter 
and to add the hairpins. The primers in the first PCR round were the forward primer, 
containing a HindIII site and 5' end of the U6 promoter, and a first reverse primer, 
containing the U6 promoter 3' end, the shRNA sense strand sequence, and the 9-
nucleotide loop. To yield the final product, in the second PCR round, the same forward 
primer was used, with a second reverse primer containing the loop sequence, the 
antisense strand sequence, the termination sequence, and a NotI recognition site, using 
the first round product as a template. The primers used to generate the PCR products are 
listed in Table 5.1. (B) PCR products were cloned into the HindIII and NotI sites. 
pGIR310 confers hygromycin resistance in amoebae and ampicillin resistance in E. coli 
bacteria. (C) Expected structure of 29-basepair shRNA before processing by Dicer The 
29-basepair stem and 9-nucleotide loop are shown. Taken from [9]. 
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III. RESULTS 
Acetate kinase operates preferentially in the direction of acetate synthesis 
Native extracts of E. histolytica cultured cells only demonstrated PPi-forming 
ACK activity in the acetate-forming (0.594 ± 0.005 µmol min-1 mg-1) direction. The 
absence of observable activity in the acetyl phosphate-forming direction is likely due to 
the low concentrations of enzyme isolated from the cells, a problem encountered upon 
initial discovery of the enzyme more than 35 years ago [7]. This finding supports 
previous work [8] on the recombinant E. histolytica ACK that the enzyme functions 
physiologically in the direction of acetate/PPi formation. We were unable to detect an 
ATP-dependent ACK activity when extracts were prepared axenically. An ATP-
dependent ACK activity was reported nearly 50 years prior, however cellular extracts 
prepared were from xenically cultured E. histolytica cells [16].  
PTA and XFP activities are absent in E. histolytica extracts. 
Other eukaryotes that have ACK also have an ORF encoding one of two bacterial 
partner enzymes. In the green algae Chlamydomonas and the oomycete Phytophthora, the 
presence of a gene encoding PTA provides a pathway for the interconversion of acetate to 
acetyl-CoA. A gene encoding XFP has been identified in all fungi that have an ACK, 
allowing for the conversion of xylulose 5-phosphate and fructose 6-phosphate to acetate 
in order to produce ATP as part of a modified pentose phosphoketolase pathway. The 
absence of ORFs encoding PTA or XFP in the most recent E. histolytica genome 
assembly indicates the possibility that either an XFP or PTA is in a region of the genome 
that has not been assembled or a new class of XFP or PTA structurally different from the 
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known bacterial enzymes is present. To rule out the presence of a PTA or XFP, 
Entamoeba cell extracts were prepared and assayed for PTA and XFP activity. PTA 
activity was not observed in the acetyl phosphate-forming or the acetyl-CoA-forming 
direction.  Likewise, XFP activity was not observed when assayed in the direction of 
acetyl phosphate formation using fructose-6 phosphate as the substrate. 
Problems with the RNA interference protocol in E. histolytica 
Initial antibiotic selection for pGIR310 was performed using 15 µg/mL of 
hygromycin. After unsuccessful transfection attempts using this antibiotic, a hygromycin 
killing curve was generated (Figure 5.3). Manual interpolation of the curve indicated an 
LD50 of approximately 1 µg/mL. Using 10X the LD50, a new concentration of 10 µg/mL 
hygromycin was utilized for future experiments. Where half the antibiotic dose was to be 
used, 5 µg/mL of hygromycin was used. This antibiotic selection was also utilized in the 
last transformation for cells transfected with pGIR308. Utilizing half of the antibiotic 
dose did not improve the experimental outcomes. 
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Figure 5.3. Hygromycin killing curve generated using E. histolytica cultures.  A LD50 of 
approximately 1 µg/mL was extrapolated manually. 
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We were unable to produce RNA interference with short hairpin RNAs using two 
separate protocols due to problems with transfection. The first protocol involves the use 
of electroporation, thereby damaging the cell membranes and encouraging the uptake of 
plasmids. The method was attempted three times with similar results. On each occasion, 
with one exception, cells that were electroporated were returned to media and began to 
divide normally until the addition of antibiotics. During one trial all cells that were 
electroporated failed to survive the 24 hour recovery period. Cells that survived 
electroporation were allowed to recover for 24, 48, or 72 hours. For cells transfected with 
pGIR310 or pGIR308 plasmids (60 µg, 80 µg, or 100 µg), 10µg/mL or 15 µg/mL of 
hygromycin was added to the cells. In each case after 24 hours all cells containing 15 
µg/mL of hygromycin did not survive. When 10 µg/mL of hygromycin was employed the 
transfected cells survived 24-48 hours. Cells transfected with pGIR209 were selected for 
using 3 µg/mL or 6 µg/mL of G418. Cells selected with 6 µg/mL of G418 did not survive 
more than 24 hours. Cells selected with 3 µg/mL of G418 survived only 48-72 hours. 
 A second protocol involving the use of the commercial transfection reagent 
Superfect® was employed after the electroporation attempts. Superfect® reagent allows 
for the formation of vesicle transformation complexes which have been used previously 
[9, 10] to successfully transfect E. histolytica cells. In this procedure, cells are incubated 
with pre-formed transformation complexes and allowed to naturally endocytose the 
plasmid. This process is thought to be advantageous over the electroporation procedure in 
that recipient cell competency is not lost due to directed damage to the cell membranes. 
Researchers utilizing this protocol for E. histolytica transfection have reported a higher 
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success rate than transfection by electroporation (personal communication, Dr. Upinder 
Singh and Dr. Richard Pearson, Stanford University).  
 The Superfect® transformation protocol was attempted on four separate occasions 
without success. In each case, 20 µg of plasmid DNA was transfected with a contact 
incubation time of three or four hours. Antibiotics employed for selection were added 
after 48 or 72 hours at concentrations of 10 µg/mL or 5 µg/mL of hygromycin for 
pGIR310 series or pGIR308 plasmids and 6 µg/mL or 3 µg/mL of G418 for cells 
transfected with the pGIR209 plasmid. Concentrations of 5 µg/mL of hygromycin and 
3µg/mL G418 or half the antibiotic dosing concentrations were utilized in the last 
transformation attempt to encourage cell growth during selection. Cells receiving full 
doses of hygromycin (10 µg/mL) or G418 (6 µg/mL) did not survive more than 48 hours. 
During the last transformation where half concentrations of antibiotics were utilized (5 
µg/mL hygromycin and 3 µg/mL G418) the cells transformed with plasmids survived up 
to 96 hours, but were inconsistent with the constructs transformed. The cells that survived 
transformation were very small in quantity (25-50 living, motile cells) after 48 hours. 
While some of these cells continued to survive, the cells doubled only once in another 48 
hours resulting in very small cells numbers that did not survive more than 96 hours. One 
exception was the flask containing cells that were incubated with Superfect® and no 
plasmid, but did contain 5 µg/mL of hygromycin. Despite the addition of antibiotics this 
culture continued to divide and increase the rate of doubling after 72 hours. By 96 hours 
10 colonies containing more than 200 cells were observed. 
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IV. DISCUSSION 
 The PPi-dependent ACK found in E. histolytica offers a unique opportunity to 
investigate the physiological roles of this novel enzyme. All of the other known ACKs 
found in all other eukaryal, bacterial, and archaeal organisms utilize ATP as a phosphoryl 
donor [4, 17, 18]. Phylogenies constructed using eukaryotic ACK sequences also support 
the novelty of this enzyme, as Entamoeba ACKs form a clade separate from the other 
eukaryotic ACKs [4]. 
 As previously mentioned, E. histolytica lacks ORFs [8] for PTA and XFP, the 
partners for ACK found in other eukaryotes that have an ACK. Furthermore, E. 
histolytica lacks the genes for other potential partner enzymes which are found in other 
organisms (Figure 5.4). However, the absence of these enzymes does not preclude the 
possibility that an evolutionarily distinct PTA or XFP is present in the parasite. We were 
unable to detect PTA and XFP activities in E. histolytica cellular extracts. The absence of 
bacterial ACK partner enzymes in Entamoeba suggests that a novel acetyl phosphate 
generating enzyme is the partner for the PPi-ACK in this protist. While the identification 
of this partner enzyme remains unknown, E. histolytica possesses a complete pentose 
phosphate pathway, but lacks a mitochondrion, and therefore TCA cycle. A novel partner 
enzyme could generate acetyl phosphate from an intermediate of the pentose phosphate 
pathway or the end product of a yet to be identified catabolic pathway. 
 
 
 
184 
 
 
 
Figure 5.4. Network of pathways involved in the metabolism of acetyl-CoA. Pathways in 
green have been identified in Entamoeba histolytica, while pathways in gray have been 
observed in species other than E. histolytica. Acetate kinase (ACK) functions in the 
interconversion of acetate and acetyl phosphate. E. histolytica specifically utilizes a PPi-
dependent ACK, which differs from the ATP-dependent ACK found in prokaryotes and 
archaea. To date, there are no known partner enzymes for PPi-dependent ACK in E. 
histolytica. 
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 Preferentially operating in the direction of acetate formation, the E. histolytica 
ACK could provide PPi which can be utilized by phosphofructokinase (PPi-PFK) and 
PPi-dependent phosphoenolpyruvate dikinase (PPDK) in glycolysis during substrate-level 
phosphorylation; the primary source of energy for the parasite (Figure 5.5). Further 
evidence supporting this physiological role includes previous observations of acetate 
fermentation by the parasite [19]. Microarray data also indicates the presence of acetate 
kinase transcripts in both cyst and trophozoite life stages of the parasite [20]. However, 
an unknown enzyme partner must exist in order to synthesize acetyl phosphate from an 
intermediate in pentose phosphate pathway or another metabolic process (Figure 5.6). 
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Figure 5.5. Proposed metabolic pathway(s) for acetate synthesis and utilization in E. 
histolytica. An extended glycolytic pathway is present in E. histolytica in which pyruvate 
is converted to acetyl-CoA by the PFOR. Acetyl-CoA can then be converted to acetate by 
and ADP-ACS or by a ACK/PTA pathway. HK, hexokinase; PPi-dependent 
phosphofructokinase, PPi-PFK; 3-PGK, 3-phosphoglycerate kinase; PPDK, 
phosphoenolpyruvate dikinase; HYD, hydrogenase; PFOR, pyruvate ferrodoxin 
oxidoreductase; ADP-ACS, ADP-forming acetyl-CoA synthetase; phosphotransacetylase, 
PTA; acetate kinase, ACK. 
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Figure 5.6. Proposed metabolic pathway(s) for PPi synthesis and utilization in E. 
histolytica. An extended glycolytic pathway is present in E. histolytica in which glucose 
is converted to acetyl-CoA utilizing PPi-dependent enzymes. Acetyl-CoA can then be 
converted to acetate by an ADP-ACS. Glucose 6-phosphate can enter the pentose 
phosphate pathway in order to generate acetyl phosphate from an unknown intermediate 
and unknown enzyme partner. Other unknown enzyme partners could be utilized to 
generate acetyl phosphate from unknown sources. PPi-dependent phosphofructokinase, 
PPi-PFK; 3-PGK, 3-phosphoglycerate kinase; PPDK, phosphoenolpyruvate dikinase; 
ADP-ACS, ADP-forming acetyl-CoA synthetase; acetate kinase; PPi-ACK. 
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Our attempts at transfections to perform RNA interference in E. histolytica were 
unsuccessful. In all experimental trials, cells transformed with plasmids containing the 
scrambled sequences did not survive any longer than cells transfected with plasmids 
capable of coding for shRNAs. Should ACK be essential for the survival of E. histolytica, 
we would expect that the parasites would not survive selection. In this case, an alternative 
inducible RNA interference system could be constructed. A tetracycline inducible system 
has already been employed in E. histolytica [21, 22] and could be modified to serve this 
purpose.  
Alternatively to an essential role in parasite metabolism, ACK may play an 
important role in other cellular processes whose disruption could impede growth and 
replication. Quantitative reverse transcriptase PCR (qRT-PCR) can be utilized to examine 
RNA levels of the scrambled control against the experimental constructs to determine 
ACK gene expression is actually being knocked down by RNA interference. ACK assays 
can also be employed to detect enzyme activity.  
Treatment for infection by E. histolytica involves the administration of two drugs. 
Metronidazole (Flagyl), a nitromidazole which interacts with protozoal ferrodoxin (PFOR 
reaction in Figure 5.3) to produce toxic byproducts is used to treat invasive trophozoites, 
and paromomycin (Humatin) an aminoglycoside, is used as a luminal amoebicide [23]. In 
vitro amoebic resistance to metronidazole and in vivo cytotoxic and nephrotoxic effects 
from paromomycin indicates a need for the identification of novel drug targets in this 
parasite.  Should the PPi-dependent ACK be essential to the organisms survival, further 
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research regarding this novel enzyme as a possible drug target for E. histolytica infection 
should be pursued.  
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 CHAPTER VI 
CONCLUDING REMARKS AND FUTURE PROSPECTS 
 Entamoeba histolytica possesses a novel PPi-dependent acetate kinase (ACK). 
This is the first PPi-dependent ACK to be biochemically and kinetically characterized and 
is the only known member of the ASKHA superfamily that can utilize PPi. The enzyme 
operates preferentially in the direction of acetate/PPi synthesis and is capable of utilizing 
acyl substrates as long as hexanoate in the direction of acetyl phosphate synthesis. The 
kinetic parameters for substrate affinity indicate that the enzyme functions as both an 
acetate and propionate kinase in the acetyl phosphate-forming direction; however, the 
low kcat raises question whether this direction of the reaction is physiological. Studies of 
the mechanism of this enzyme indicates that the PPi-ACK follows a sequential 
mechanism, supporting a direct in-line phosphoryl transfer mechanism previously 
reported in the most well characterized ATP-dependent ACK found in Methanosarcina 
thermophila. 
 A modified hydroxamate assay was developed for measuring the synthesis of 
acetyl phosphate to overcome problems associated with using multiple coupled enzymes 
to detect ACK activity. The assay can be used to detect ACK activity of both ATP-
dependent and PPi-dependent acetate kinases in the direction of acetyl phosphate 
synthesis. Modifications of this assay may be used for other enzymes that utilize acetyl 
phosphate or acetyl-CoA as a substrate, such as ACS, ADP-ACS, or PTA.  
 Although a number of conserved catalytically important residues are present in 
the E. histolytica PPi-ACK, this investigation revealed a number of significant active site 
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changes in comparison to the well characterized M. thermophila ATP-dependent ACK. 
The residues His117, His172, Val87, Thr201, Thr15, Arg274, and Asp272 appear to be essential 
for catalysis in the direction of acetate synthesis. Furthermore, His117 appears to be 
critically important for binding acetyl phosphate and therefore important in acetate/PPi 
synthesis reactions. While Thr15 of the E. histolytica ACK appears to lie outside of the 
active site, the residue was implicated in catalysis. For this process to occur, the residue 
would need to be brought into the active site for substrate interaction. Therefore a logical 
proposition is that the E. histolytica ACK active site undergoes a claw-like closure; a 
process also observed in the M. thermophila ACK. Closure of the active site would also 
bring Thr15 into close proximity with Arg274 which is also implicated in catalysis. The 
active site of the E. histolytica ACK also lacks the adenosine pocket present in the ATP-
dependent, M. thermophila ACK. 
Based on the results presented in this dissertation, the data supports the hypothesis 
that the E. histolytica ACK operates physiologically in the direction of PPi synthesis. PPi 
generated from this reaction may be utilized by the glycolytic enzymes PPi-dependent 
phosphofructokinase (PPi-PFK) and PPi-dependent phosphoenolpyruvate dikinase 
(PPDK) in substrate-level phosphorylation for energy generation by the parasite. 
RNA interference of E. histolytica ACK was unable to be carried out due to 
problems with transfection of plasmid DNA into the parasite. However, data garnered 
from cellular extracts indicates the presence of the PPi-dependent ACK, and absence of 
an ATP-dependent ACK activity. Utilization of PPi by PPi-dependent glycolytic enzymes 
produced by the parasite’s ACK suggests an important role for this enzyme in 
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Entamoeba’s metabolism. Prokaryotic ACK partner enzyme activities of 
phosphotransacetylase (PTA) and xylulose 5-phosphate/fructose 6- phosphate 
phosphoketolase (XFP) were absent in parasite cellular extracts. The absence of bacterial 
ACK partner enzymes in Entamoeba suggests that a novel acetyl phosphate generating 
enzyme is the partner for the PPi-ACK in this protist. A novel partner enzyme could 
generate acetyl phosphate from an intermediate of the pentose phosphate pathway or the 
end product of a yet to be identified catabolic pathway. Identification and 
characterization of the Entamoeba PPi-ACK partner enzyme will provide unique insights 
into the metabolism of this important protist. 
 This study has provided significant knowledge on a novel PPi-dependent ACK, 
and helps gain a better understanding of ACKs and the ASKHA enzyme superfamily. 
Future experiments investigating additional active site residues will assist in the 
understanding of the overall mechanism of this novel ACK. Continued research on the 
ack RNA knockdown may lead to a better understanding of the essentiality of this 
enzyme in E. histolytica physiology, and the possibility of identifying new drug targets 
for the treatment of amoebiasis.  
 
 
